https://curecurrent.com/trials/long-term-effects-of-transcranial-direct-current-stimulation-tdcs-on-patients-with-phantom-limb-pain-plp-21001https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-multiple-rising-doses-of-bi-187004-in-patients-with-type-2-21002https://curecurrent.com/trials/safety-study-of-stem-cells-treatment-in-diabetic-foot-ulcers-21003https://curecurrent.com/trials/evaluation-of-pressure-distribution-of-kyboot-shoes-in-comparison-to-other-foot-wear-21004https://curecurrent.com/trials/diabetes-outcomes-and-nurse-case-manager-study-21005https://curecurrent.com/trials/liraglutide-in-type-1-diabetes-21006https://curecurrent.com/trials/polyethylene-glycol-loxenatide-pharmacokinetics-study-in-subjects-with-normal-and-insufficiency-renal-function-21007https://curecurrent.com/trials/user-performance-evaluation-of-contour-plus-accu-chek-active-accu-chek-performa-and-onetouch-select-simple-blood-glucose-21008https://curecurrent.com/trials/effects-of-pancreaticoduodenectomy-on-glucose-metabolism-21009https://curecurrent.com/trials/metformin-in-obese-non-diabetic-pregnant-women-21010https://curecurrent.com/trials/gather-mhealth-india-rct-for-behavior-and-health-outcomes-21011https://curecurrent.com/trials/precise-a-prospective-multi-center-evaluation-of-the-accuracy-of-a-novel-continuous-implanted-glucose-sensor-21012https://curecurrent.com/trials/study-of-liraglutide-in-individuals-with-type-2-diabetes-using-insulin-21013https://curecurrent.com/trials/diabetes-screening-prevention-for-people-with-learning-intellectual-disabilities-stop-diabetes-study-21014https://curecurrent.com/trials/nitric-oxide-generating-gel-dressing-in-patients-with-diabetic-foot-ulcers-21015https://curecurrent.com/trials/gut-hormone-profiling-in-obese-patients-with-type-2-diabetes-mk-0000-134-21016https://curecurrent.com/trials/surrogate-markers-for-sudden-cardiac-death-in-patients-with-diabetes-mellitus-and-end-stage-renal-disease-21017https://curecurrent.com/trials/less-neuropathy-after-yoga-managing-diabetic-neuropathy-with-yoga-21018https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-and-pharmacodynamic-characteristics-of-explorative-formulations-of-insulin-deglu-21019https://curecurrent.com/trials/a-role-for-brown-adipose-tissue-in-postprandial-thermogenesis-21020https://curecurrent.com/trials/beneficial-effect-of-xylose-consumption-on-postprandial-hyperglycemia-21021https://curecurrent.com/trials/ex-vivo-immunotherapy-for-hyperglycemia-in-type-2-diabetes-mellitus-21022https://curecurrent.com/trials/effects-of-personalized-dietary-advice-on-health-status-of-diabetes-type-2-patients-21023https://curecurrent.com/trials/trial-to-assess-the-efficacy-of-neuroprotective-drugs-administered-topically-to-prevent-or-arrest-diabetic-retinopathy-21024https://curecurrent.com/trials/combined-vasopressin-methylprednisolone-and-epinephrine-for-inhospital-cardiac-arrest-21025https://curecurrent.com/trials/0-3-sodium-hyaluronate-in-the-treatment-of-dry-eye-of-diabetic-patients-21026https://curecurrent.com/trials/physical-activity-hypertension-diabetes-and-coronary-heart-disease-21027https://curecurrent.com/trials/education-effectiveness-for-type-1-diabetes-mellitus-on-insulin-pump-therapy-21028https://curecurrent.com/trials/albiglutide-versus-placebo-added-on-to-basal-bolus-insulin-therapy-in-subjects-with-type-2-diabetes-mellitus-21029https://curecurrent.com/trials/feasibility-of-using-a-smart-phone-application-for-self-titration-of-insulin-on-glycemic-control-in-patients-with-t2dm-21030https://curecurrent.com/trials/effects-of-glp-1-on-chronic-heart-failure-21031https://curecurrent.com/trials/purified-anthocyanins-supplementation-and-high-density-lipoprotein-hdl-function-21032https://curecurrent.com/trials/screening-for-liver-fibrosis-by-using-non-invasive-methods-in-patients-with-diabetes-a-prospective-study-21033https://curecurrent.com/trials/towards-simple-and-non-invasive-assessment-of-residual-beta-cell-function-in-type-1-diabetes-21034https://curecurrent.com/trials/mk-1006-single-dose-study-in-japanese-type-2-diabetes-patients-mk-1006-005-21035https://curecurrent.com/trials/a-clinical-study-to-compare-the-pharmacokinetic-characteristics-of-ckd-395-0-25-750-mg-in-healthy-male-volunteers-21036https://curecurrent.com/trials/the-effect-of-90-day-oral-testosterone-therapy-in-chinese-males-with-type-2-diabetes-t2dm-21037https://curecurrent.com/trials/an-efficacy-and-safety-study-of-beloranib-in-obese-subjects-with-type-2-diabetes-mellitus-21038https://curecurrent.com/trials/intravitreal-ranibizumab-injection-as-adjuvant-in-the-treatment-of-postvitrectomy-diabetic-vitreous-hemorrhage-accompani-21039https://curecurrent.com/trials/effect-of-sleep-apnea-treatment-on-type-1-diabetes-21040https://curecurrent.com/trials/effect-of-preoperative-topical-ketorolac-on-aqueous-cytokine-levels-and-macular-thickness-in-cataract-surgery-patients-21041https://curecurrent.com/trials/glycemic-responses-and-of-the-autonomic-cardiac-function-in-diabetes-type-2-women-post-resistance-exercise-21042https://curecurrent.com/trials/the-effect-of-melatonin-on-early-signs-of-hypertension-in-teenagers-with-diabetes-mellitus-type-1-21043https://curecurrent.com/trials/pascal-laser-platform-produces-less-pain-responses-compared-to-conventional-laser-system-21044https://curecurrent.com/trials/clinical-and-microbiological-evaluation-of-periodontal-treatment-of-diabetic-patients-a-longitudinal-study-21045https://curecurrent.com/trials/use-of-mobile-technology-to-promote-sustained-lifestyle-changes-to-prevent-type-2-diabetes-in-india-and-the-uk-21046https://curecurrent.com/trials/sitagliptin-in-prevention-of-type-2-diabetes-mellitus-21047https://curecurrent.com/trials/salt-sensitivity-cardiovascular-and-metabolic-disease-21048https://curecurrent.com/trials/clinical-trial-for-liquid-food-inslow-21049https://curecurrent.com/trials/governance-of-diabetes-management-in-non-specialistic-hospital-settings-21050https://curecurrent.com/trials/medico-gdm-trial-metformine-to-prevent-gestational-diabetes-mellitus-21051https://curecurrent.com/trials/pharmacokinetic-pk-bioequivalence-and-pharmacodynamics-of-julphar-insulin-r-and-huminsulin-normal-21052https://curecurrent.com/trials/efficacy-study-of-izn-6d4-gel-for-the-treatment-of-diabetic-foot-ulcers-21053https://curecurrent.com/trials/incentives-for-internet-based-adherence-to-smbg-for-teens-with-t1d-21054https://curecurrent.com/trials/proof-of-concept-design-validation-in-patient-with-hard-to-heal-wounds-such-as-pressure-ulcer-diabetic-foot-ulcer-and-le-21055https://curecurrent.com/trials/aerobic-training-in-pregnant-women-with-gestational-diabetes-and-chronic-hypertension-21056https://curecurrent.com/trials/effect-of-personalized-feedback-report-and-peer-support-on-diabetes-21057https://curecurrent.com/trials/the-long-term-effect-of-adjustable-spaatz-3-intragastric-balloon-on-weight-loss-21058https://curecurrent.com/trials/graz-study-on-the-risk-of-atrial-fibrillation-21059https://curecurrent.com/trials/quantification-of-the-dipeptidyl-peptidase-dpp-4-inhibition-mediated-enhancement-of-the-activity-of-the-entero-insular-a-21060https://curecurrent.com/trials/improving-the-quality-of-patient-care-by-using-a-clinical-expert-system-21061https://curecurrent.com/trials/pizza-salami-study-in-children-and-adolescents-with-type-1-diabetes-21062https://curecurrent.com/trials/a-study-to-test-mk-0941-in-patients-with-type-2-diabetes-mellitus-with-inadequate-glycemic-control-on-metformin-mk-0941-21063https://curecurrent.com/trials/impact-of-a-diabetes-camp-on-glycemic-control-among-children-and-adolescents-living-with-type-1-diabetes-in-cameroon-21064https://curecurrent.com/trials/efficacy-of-pirfenidone-plus-modd-in-diabetic-foot-ulcers-21065https://curecurrent.com/trials/low-glycemic-index-diets-vs-high-cereal-fibre-diets-in-type-2-diabetes-21066https://curecurrent.com/trials/periodontal-treatment-in-non-controlled-type-2-diabetes-mellitus-patients-clinical-trial-21067https://curecurrent.com/trials/effect-of-the-dpp-4-inhibitor-sitagliptin-on-islet-function-after-mixed-meal-in-patients-with-type-2-diabetes-21068https://curecurrent.com/trials/study-on-lixisenatide-and-counterregulation-to-hypoglycemia-21069https://curecurrent.com/trials/effects-of-adjunct-photodynamic-therapy-in-the-treatment-of-type-2-diabetic-patients-with-chronic-periodontitis-21070https://curecurrent.com/trials/pharmacokinetics-study-of-dipeptidyl-peptidase-4-inhibitor-to-control-type-2-diabetes-mellitus-21071https://curecurrent.com/trials/peripheral-insulin-uptake-in-type-2-diabetes-mellitus-and-in-non-diabetic-individuals-21072https://curecurrent.com/trials/safeguard-pleiotropic-effects-of-incretin-based-therapies-21073https://curecurrent.com/trials/insulin-therapy-for-post-transplant-glucocorticoid-induced-hyperglycemia-21074https://curecurrent.com/trials/liraglutide-use-in-prader-willi-syndrome-21075https://curecurrent.com/trials/fruits-vegetables-and-whole-grains-a-community-based-intervention-21076https://curecurrent.com/trials/effects-of-exenatide-in-type-2-diabetic-patients-with-congestive-heart-failure-21077https://curecurrent.com/trials/low-glycemic-index-diet-with-canola-oil-for-type-2-diabetics-21078https://curecurrent.com/trials/low-glycemic-index-diets-with-pulses-in-type-2-diabetes-21079https://curecurrent.com/trials/effect-of-bariatric-surgery-on-gut-hormones-production-and-cure-of-type-2-diabetes-mellitus-21080https://curecurrent.com/trials/educational-efficacy-assessment-of-a-serious-game-to-teach-insulin-therapy-to-primary-care-physicians-21081https://curecurrent.com/trials/the-effect-of-a-gastric-bypass-on-type-2-diabetes-in-the-morbidly-obese-patient-21082https://curecurrent.com/trials/utilization-of-platelet-gel-for-treatment-of-diabetic-foot-ulcers-21083https://curecurrent.com/trials/improving-glycaemic-control-with-l-carnitine-21084https://curecurrent.com/trials/insulin-sensitivity-of-the-human-cns-system-fmri-study-with-intranasal-insulin-application-21085https://curecurrent.com/trials/effects-of-low-power-laser-therapy-on-muscle-performance-isokinetic-pre-exercise-in-individuals-with-diabetes-mellitus-t-21086https://curecurrent.com/trials/retinal-ganglion-cell-complex-changes-by-optical-coherence-tomography-in-diabetic-patients-without-retinopathy-21087https://curecurrent.com/trials/web-based-support-for-people-with-type-2-diabetes-21088https://curecurrent.com/trials/regulation-of-endogenous-glucose-production-by-brain-insulin-action-21089https://curecurrent.com/trials/rct-evaluating-effects-of-cosmos-caudatus-ulam-raja-in-t2dm-patients-21090https://curecurrent.com/trials/efficacy-and-safety-of-smoking-cessation-with-varenicline-tartrate-in-diabetic-smokers-diasmoke-21091https://curecurrent.com/trials/hyperbaric-oxygen-therapy-and-insulin-resistance-hotair2-effect-of-one-hbo-session-21092https://curecurrent.com/trials/the-effect-of-aquacel-ag-extra-dressing-on-wound-biofilms-21093https://curecurrent.com/trials/hypertension-and-diabetes-initiative-improving-hypertension-control-in-individuals-with-diabetes-21094https://curecurrent.com/trials/a-study-of-intracellular-signaling-in-muscle-and-fat-cells-during-ketosis-21095https://curecurrent.com/trials/study-of-circadian-clock-properties-in-healthy-subjects-obese-and-type-2-diabetic-patients-21096https://curecurrent.com/trials/eradication-of-gut-microbiota-21097https://curecurrent.com/trials/acute-regulation-of-intestinal-and-hepatic-lipoprotein-production-by-glucagon-21098https://curecurrent.com/trials/a-trial-to-compare-the-pharmacodynamic-and-pharmacokinetic-properties-of-biochaperone-combo-with-humalog-mix25-and-with-21099https://curecurrent.com/trials/involvement-of-extrapancreatic-factors-on-gastrointestinal-mediated-glucose-disposal-21100https://curecurrent.com/trials/endogenous-glucoseproduction-in-patients-with-type-2-diabetes-mellitus-during-oral-glucose-and-iv-glucose-infusion-21101https://curecurrent.com/trials/effects-of-tianqi-capsule-on-glucose-variability-in-patients-with-type-2-diabetes-21102https://curecurrent.com/trials/effectiveness-and-cost-effectiveness-of-the-diabetes-integrated-care-breakthrough-collaborative-21103https://curecurrent.com/trials/development-of-rational-ways-of-medical-and-non-medical-treatment-methods-for-metabolic-syndrome-21104https://curecurrent.com/trials/effects-of-standing-and-light-intensity-activity-on-ambulatory-blood-pressure-and-blood-glucose-21105https://curecurrent.com/trials/inulin-scfa-production-and-metabolic-response-21106https://curecurrent.com/trials/spectral-domain-optical-coherence-tomography-of-the-eye-21107https://curecurrent.com/trials/the-drug-drug-interaction-of-shr3824-and-sp2086-21108https://curecurrent.com/trials/statin-lowering-testosterone-and-sexual-function-21109https://curecurrent.com/trials/comparative-study-of-antibacterial-effect-on-silver-dressing-of-negative-pressure-wound-21110https://curecurrent.com/trials/a-clinical-study-to-evaluate-safety-tolerability-and-pharmacokinetics-of-oral-zygk1-in-healthy-volunteers-21111https://curecurrent.com/trials/effect-of-bile-acid-sequestration-on-postprandial-glp-1-secretion-glucose-homeostasis-and-gut-microbiota-21112https://curecurrent.com/trials/effect-of-smartphone-app-on-activity-21113https://curecurrent.com/trials/obesity-and-metabolic-surgery-in-patients-with-type-i-diabetes-21114https://curecurrent.com/trials/obliterating-diabetic-microangiopathy-of-the-diabetic-foot-21115https://curecurrent.com/trials/effects-of-vildagliptine-and-glimepiride-on-glucose-variability-21116https://curecurrent.com/trials/effect-of-islet-autotransplantation-compared-to-oral-antidiabetic-drug-21117https://curecurrent.com/trials/using-combined-instantaneous-and-multidimensional-feedback-to-support-a-change-in-physical-activity-behaviour-21118https://curecurrent.com/trials/pioglitazone-versus-metformin-in-type-2-diabetes-21119https://curecurrent.com/trials/25gr-glucomedics-vs-25gr-zusto-21120https://curecurrent.com/trials/sitagliptin-dpp-4-inhibitor-and-nph-insulin-in-patients-with-t2d-21121https://curecurrent.com/trials/safety-and-efficacy-of-acarbose-saxagliptin-compared-with-metformin-saxagliptin-in-patients-with-type-2-diabetes-21122https://curecurrent.com/trials/the-effect-of-n-3-fatty-acid-supplementation-on-serum-levels-and-gene-expression-of-type2-diabetes-patient-21123https://curecurrent.com/trials/the-effect-of-online-based-mentoring-program-on-the-blood-glucose-and-satisfaction-score-in-type-1-diabetes-patients-21124https://curecurrent.com/trials/evaluation-of-diabetic-effects-on-clinical-outcomes-after-sirolimus-eluting-stents-in-the-asian-population-21125https://curecurrent.com/trials/improving-postprandial-glycaemia-by-a-new-developed-closed-loop-control-system-closedloop4meals-21126https://curecurrent.com/trials/effects-of-various-bariatric-surgical-procedures-on-intestinal-trl-metabolism-in-obese-type-2-diabetic-patients-21127https://curecurrent.com/trials/the-balance-control-mechanism-of-dpn-patients-21128https://curecurrent.com/trials/a-clinical-trial-analyzing-effects-of-prokinetic-drug-on-the-blood-glucose-in-patients-with-type-2-diabetes-21129https://curecurrent.com/trials/efficacy-and-safety-of-resolute-zotarolimus-eluting-stent-in-treatment-of-chinese-diabetic-coronary-lesions-21130https://curecurrent.com/trials/purified-anthocyanins-supplementation-in-type-2-diabetes-mellitus-21131https://curecurrent.com/trials/phase-2-study-of-ngm282-in-patients-with-type-2-diabetes-21132https://curecurrent.com/trials/acupuncture-in-the-complementary-treatment-of-diabetes-mellitus-type-ii-21133https://curecurrent.com/trials/closed-loop-control-of-postprandial-glucose-levels-in-adults-with-type-1-diabetes-21134https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-daily-oral-tak-875-25-and-50mg-in-asia-pacific-adults-with-type-2-diabetes-21135https://curecurrent.com/trials/measurement-of-the-pancreas-function-in-patients-with-more-than-one-pancreas-after-liver-and-small-bowel-transplantation-21136https://curecurrent.com/trials/elevated-circulating-ffa-and-intrahepatic-lipid-content-21137https://curecurrent.com/trials/metabolic-complications-following-knee-injury-in-young-and-middle-aged-patients-21138https://curecurrent.com/trials/benefit-of-iqp-vv-102-in-reducing-postprandial-glucose-level-in-overweight-caucasian-subjects-21139https://curecurrent.com/trials/the-effect-of-hypoglycaemia-on-brain-lactate-accumulation-and-cerebral-blood-flow-21140https://curecurrent.com/trials/can-topical-oxygen-therapy-natrox-improve-wound-healing-in-diabetic-foot-ulcers-21141https://curecurrent.com/trials/meta-analyses-of-the-effect-of-legumes-on-blood-pressure-21142https://curecurrent.com/trials/a-series-of-systematic-reviews-and-meta-analyses-of-the-effect-of-vegetarian-vegan-diets-on-cardiometabolic-risk-21143https://curecurrent.com/trials/system-accuracy-evaluation-of-6-ce-marked-blood-glucose-monitoring-system-following-iso-15197-2013-21144https://curecurrent.com/trials/effect-of-macronutrient-supplementation-on-glycemic-index-of-pita-bread-21145https://curecurrent.com/trials/effect-of-exercise-frequency-on-metabolic-control-and-heart-function-in-type-2-diabetes-21146https://curecurrent.com/trials/postprandial-blood-glucose-control-with-biochaperone-combo-and-insulin-lispro-humalog-mix-25-in-people-with-type-1-diabe-21147https://curecurrent.com/trials/hybrid-artificial-pancreas-in-home-setting-21148https://curecurrent.com/trials/efficacy-and-safety-of-lidocaine-infusion-treatment-in-management-of-neuropathic-pain-21149https://curecurrent.com/trials/norvit-and-wenbit-long-term-follow-up-21150https://curecurrent.com/trials/pharmaceutical-care-program-for-type-2-diabetes-mellitus-21151https://curecurrent.com/trials/chemerin-and-il-6-levels-in-diabetes-and-periodontitis-21152https://curecurrent.com/trials/gingival-crevicular-fluid-vaspin-and-omentin-levels-in-type-2-diabetic-patients-with-chronic-periodontitis-21153https://curecurrent.com/trials/implementing-online-patient-provider-communication-into-clinical-practice-21154https://curecurrent.com/trials/acupuncture-for-diabetic-gastroparalysis-a-randomized-controlled-trial-21155https://curecurrent.com/trials/pharmacokinetics-study-of-gamma-aminobutyric-acid-21156https://curecurrent.com/trials/long-term-excess-mortality-of-acute-myocardial-infarction-in-patients-with-and-without-diabetes-a-population-based-cohor-21157https://curecurrent.com/trials/the-features-behind-the-beneficial-effects-of-interval-walking-21158https://curecurrent.com/trials/drug-trial-of-lixisenatide-on-gastric-emptying-and-blood-pressure-drops-in-type-2-diabetics-and-healthy-people-21159https://curecurrent.com/trials/effects-of-sitagliptin-on-gastric-emptying-in-healthy-subjects-21160https://curecurrent.com/trials/comparison-of-vildagliptin-vs-glimepiride-on-glucose-variability-in-metformin-uncontrolled-type-2-diabetic-patients-21161https://curecurrent.com/trials/reliability-of-insulin-by-jet-injection-21162https://curecurrent.com/trials/life-long-monitoring-of-diabetes-mellitus-in-veneto-region-21163https://curecurrent.com/trials/life-long-monitoring-of-frail-patients-with-chronic-diseases-21164https://curecurrent.com/trials/effect-of-smart-phone-application-on-the-individualized-management-of-chinese-diabetic-patients-21165https://curecurrent.com/trials/blood-sugar-responses-by-physical-activity-level-and-intensity-21166https://curecurrent.com/trials/bone-marrow-derived-stem-cell-transplantation-in-t2dm-21167https://curecurrent.com/trials/efficacy-and-safety-of-voice-inception-technique-based-u-healthcare-service-in-patients-with-type-2-diabetes-mellitus-21168https://curecurrent.com/trials/the-usefulness-of-postprandial-triglyceride-for-assessment-of-cardiovascular-risk-21169https://curecurrent.com/trials/comparison-of-diabetes-retinopathy-among-type-2-diabetic-patients-treated-with-different-regimens-21170https://curecurrent.com/trials/association-of-kisspeptin-levels-with-insulin-secretion-in-diabetes-mellitus-21171https://curecurrent.com/trials/a-one-year-randomized-controlled-trial-evaluating-the-impact-of-pioglitazone-versus-linagliptin-on-bone-turnover-markers-21172https://curecurrent.com/trials/bioequivalence-between-two-explorative-insulin-degludec-formulations-and-between-two-explorative-idegasp-formulations-in-21173https://curecurrent.com/trials/association-of-agtr1-and-acacb-gene-polymorphism-and-diabetic-nephropathy-in-type-2-diabetes-21174https://curecurrent.com/trials/comparison-of-thrice-daily-biphasic-human-insulin-with-basal-bolus-regimen-in-type-2-diabetes-mellitus-patients-21175https://curecurrent.com/trials/oral-cholecalciferol-in-prevention-of-type-2-diabetes-mellitus-21176https://curecurrent.com/trials/efficacy-of-laparoscopic-sleeve-gastrectomy-and-intensive-medical-management-in-obese-type-2-diabetes-21177https://curecurrent.com/trials/tissue-distribution-of-f18-fdg-labeled-abmsct-in-patients-with-type2-diabetes-mellitus-21178https://curecurrent.com/trials/comparison-of-explorative-formulation-of-insulin-degludec-and-insulin-aspart-co-formulation-versus-explorative-formulati-21179https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-explorative-formulation-of-insulin-degludec-21180https://curecurrent.com/trials/comparison-of-idegasp-inclusive-three-explorative-formulations-with-insulin-degludec-and-insulin-aspart-separately-injec-21181https://curecurrent.com/trials/safety-pharmacokinetics-and-pharmacodynamics-of-two-idegasp-one-explorative-preparations-and-two-insulin-degludec-one-ex-21182https://curecurrent.com/trials/efficacy-study-of-ultrasound-assisted-debridement-to-influence-wound-healing-21183https://curecurrent.com/trials/the-effect-of-glp-1-on-postprandial-glucagon-secretion-independent-of-the-gastric-emptying-rate-21184https://curecurrent.com/trials/treatment-of-prp-on-diabetes-wound-21185https://curecurrent.com/trials/renin-and-aldosterone-levels-in-the-preterm-neonate-at-risk-for-hypertension-21186https://curecurrent.com/trials/evaluate-the-effect-of-saxagliptin-on-gut-microbiota-in-patients-with-newly-diagnosed-type-2-diabetes-21187https://curecurrent.com/trials/investigation-of-pharmacodynamic-characteristics-of-explorative-formulation-of-insulin-degludec-in-male-subjects-with-ty-21188https://curecurrent.com/trials/efficacy-of-autologous-bone-marrow-derived-stem-cell-transplantation-in-patients-with-type-2-diabetes-mellitus-2-21189https://curecurrent.com/trials/efficacy-of-autologous-bone-marrow-derived-stem-cell-transplantation-in-patients-with-type-2-diabetes-mellitus-21190https://curecurrent.com/trials/antipsychotics-and-risk-of-hyperglycemic-emergencies-21191https://curecurrent.com/trials/evaluation-of-the-effect-of-pramlintide-on-satiety-and-food-intake-21192https://curecurrent.com/trials/comparing-the-pharmacodynamics-and-pharmacokinetics-of-explorative-formulation-of-insulin-degludec-with-insulin-glargine-21193https://curecurrent.com/trials/urine-plasminogen-as-a-predictor-for-development-of-preeclampsia-in-pregnant-women-with-type-1-diabetes-mellitus-21194https://curecurrent.com/trials/a-comparison-of-european-and-chinese-blood-sugar-responses-21195https://curecurrent.com/trials/safety-of-allo-asc-dfu-in-the-patients-with-diabetic-foot-ulcers-21196https://curecurrent.com/trials/25-hydroxyvitamin-d-and-fatigue-the-vitality-study-21197https://curecurrent.com/trials/the-survey-of-ipragliflozin-treatment-in-elderly-type2-diabetes-patients-21198https://curecurrent.com/trials/e4e-health-professional-education-for-improving-care-for-canadian-aboriginal-populations-21199https://curecurrent.com/trials/the-impact-of-resistance-training-on-type-2-diabetes-patients-21200https://curecurrent.com/trials/dancefit-prime-a-dance-based-physical-activity-and-nutritional-intervention-for-primary-care-a-feasibility-study-21201https://curecurrent.com/trials/coronary-blood-flow-regulation-during-general-anesthesia-21202https://curecurrent.com/trials/the-effect-of-liraglutide-on-left-ventricular-function-in-chronic-heart-failure-patients-with-and-without-type-2-diabete-21203https://curecurrent.com/trials/effects-of-triacylglycerol-structure-on-gut-hormones-and-haemostatic-markers-21204https://curecurrent.com/trials/extended-niacin-laropiprant-in-patients-with-type-2-diabetes-0524a-069-21205https://curecurrent.com/trials/platelet-dependent-thrombosis-a-placebo-controlled-trial-of-antiplatelet-therapy-clopidogrel-21206https://curecurrent.com/trials/proof-of-confidence-study-of-ccr2-antagonist-bms-741672-in-insulin-resistance-21207https://curecurrent.com/trials/to-assess-the-accuracy-of-the-ezscan-study-in-the-screening-for-diabetic-nephropathy-21208https://curecurrent.com/trials/assessment-of-thrombogenicity-in-acute-coronary-syndrome-21209https://curecurrent.com/trials/phenotypes-of-nonproliferative-diabetic-retinopathy-in-dm-2-patients-identified-by-oct-cfp-rla-and-mferg-diamarker-21210https://curecurrent.com/trials/haptoglobin-and-diabetes-complications-in-pregnancy-21211https://curecurrent.com/trials/tweesteden-mild-stenosis-study-21212https://curecurrent.com/trials/community-health-workers-in-diabetes-care-in-american-samoa-21213https://curecurrent.com/trials/intraportal-or-intramuscular-site-for-islets-in-simultaneous-islet-and-kidney-transplantation-21214https://curecurrent.com/trials/teneligliptin-mp-513-vs-placebo-in-patient-with-metformin-monotherapy-21215https://curecurrent.com/trials/20-years-results-by-hbp-and-dbp-in-patients-with-type-2-diabetes-mellitus-after-following-up-21216https://curecurrent.com/trials/safety-and-tolerability-of-insulin-degludec-liraglutide-a3-in-healthy-subjects-21217https://curecurrent.com/trials/algorithm-to-control-postprandial-post-exercise-and-night-glucose-excursions-in-a-portable-closed-loop-format-21218https://curecurrent.com/trials/a-clinical-study-to-compare-the-pharmacokinetic-characteristics-of-ckd-395-0-5-1000-mg-in-healthy-male-volunteers-21219https://curecurrent.com/trials/integrated-clinical-evaluation-of-traditional-chinese-medicine-tcm-and-conventional-medicine-on-diabetic-patients-21220https://curecurrent.com/trials/effect-of-resistance-training-on-metabolic-control-and-outcome-in-prediabetes-nmr-based-metabonomics-21221https://curecurrent.com/trials/p53-gene-therapy-in-treatment-of-diabetes-concurrent-with-hepatocellular-carcinoma-21222https://curecurrent.com/trials/a-study-of-ly2189265-in-japanese-patients-with-type-2-diabetes-21223https://curecurrent.com/trials/comparison-of-insulin-degludec-with-insulin-glargine-in-subjects-with-type-1-diabetes-mellitus-21224https://curecurrent.com/trials/effects-of-pomegranate-juice-on-oxidative-stress-in-patients-with-type2-diabetes-21225https://curecurrent.com/trials/soccer-and-health-diet-and-exercise-on-type-2-diabetes-mellitus-21226https://curecurrent.com/trials/medium-term-health-coaching-and-life-long-monitoring-in-diabetes-mellitus-21227https://curecurrent.com/trials/meta-analyses-of-dietary-pulses-and-cardiometabolic-risk-21228https://curecurrent.com/trials/plant-based-ingredient-on-post-prandial-glucose-in-type-ii-diabetes-21229https://curecurrent.com/trials/vitamin-d-for-the-prevention-of-diabetes-type-2-21230https://curecurrent.com/trials/maternal-thyroid-function-in-early-pregnancy-and-their-relationship-with-gestational-diabetes-mellitus-21231https://curecurrent.com/trials/dose-ranging-study-to-evaluate-the-effectiveness-and-tolerability-of-mk0736-in-patients-with-type-2-diabetes-mellitus-t2-21232https://curecurrent.com/trials/effect-of-vitamin-d-supplementation-on-glucose-tolerance-in-subjects-at-risk-for-diabetes-with-low-vitamin-d-21233https://curecurrent.com/trials/effect-of-diacerein-in-the-metabolic-control-of-patients-with-dm-type-2-and-secondary-failure-to-metformin-21234https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-study-of-mt-3995-at-a-low-dose-in-subjects-with-diabetic-nephropathy-21235https://curecurrent.com/trials/model-driven-diabetes-care-21236https://curecurrent.com/trials/the-effect-of-walking-meditation-training-on-glycemic-control-and-vascular-function-in-patients-with-type-2-diabetes-21237https://curecurrent.com/trials/short-chain-fatty-acid-metabolism-and-energy-metabolism-21238https://curecurrent.com/trials/glucose-in-dialysis-water-in-diabetics-with-chronic-renal-failure-21239https://curecurrent.com/trials/exenatide-versus-glimepiride-in-patients-with-type-2-diabetes-21240https://curecurrent.com/trials/differences-in-endothelial-function-amongst-sitagliptin-and-liraglutide-users-21241https://curecurrent.com/trials/community-based-sport-programme-and-type-2-diabetes-21242https://curecurrent.com/trials/corneal-changes-in-diabetics-after-phacoemulsification-21243https://curecurrent.com/trials/evaluation-of-the-metformin-effect-on-methylglyoxal-in-patients-with-type-2-diabetes-21244https://curecurrent.com/trials/moca-test-for-the-early-detection-of-mild-cognitive-impairment-during-annual-assessment-of-young-adults-with-diabetes-an-21245https://curecurrent.com/trials/guided-self-determination-promoting-self-management-in-type-1-diabetes-21246https://curecurrent.com/trials/serial-vasopressin-and-copeptin-levels-in-children-with-sepsis-and-septic-shock-21247https://curecurrent.com/trials/walking-away-structured-education-versus-written-information-for-individuals-with-high-risk-of-developing-type-2-diabete-21248https://curecurrent.com/trials/profiling-of-original-cellular-and-humoral-biomarkers-of-type-1-diabetes-21249https://curecurrent.com/trials/dose-range-finding-study-for-mk0893-0893-008-21250https://curecurrent.com/trials/effect-of-stevioside-in-postpandrial-glucose-in-healthy-adults-21251https://curecurrent.com/trials/community-health-worker-reduces-care-utilization-21252https://curecurrent.com/trials/a-phase-1-single-dose-study-to-evaluate-the-safety-and-pharmacokinetics-of-medi0382-in-healthy-volunteers-21253https://curecurrent.com/trials/type-2-diabetes-prevention-21254https://curecurrent.com/trials/sex-differences-in-the-risk-of-cardiovascular-diseases-associated-with-diabetes-21255https://curecurrent.com/trials/post-prandial-glucose-and-insulin-levels-in-type-2-diabetes-mellitus-patients-after-consumption-of-ready-to-eat-mixed-me-21256https://curecurrent.com/trials/day-night-rhythm-in-human-skeletal-muscle-21257https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-er-niacin-laropiprant-laropiprant-er-niacin-and-placebo-on-urinary-prostanoid-metabol-21258https://curecurrent.com/trials/long-acting-insulin-glargine-titration-web-tool-lthome-vs-enhanced-usual-therapy-of-glargine-titration-21259https://curecurrent.com/trials/comparison-of-effects-of-telmisartan-and-valsartan-on-neointima-volume-in-diabetes-21260https://curecurrent.com/trials/ara290-in-t2d-effects-of-ara-290-an-erythropoietin-analogue-in-prediabetes-and-type-2-diabetes-21261https://curecurrent.com/trials/evaluation-of-the-glucoregulatory-effects-of-glucagon-like-peptide-1-receptor-glp-1-receptor-activation-in-participants-21262https://curecurrent.com/trials/oneshot-renal-denervation-registry-21263https://curecurrent.com/trials/beneficial-effects-of-a-polyphenol-enriched-beverage-on-type-2-diabetes-prevention-and-on-cardiovascular-risk-profile-of-21264https://curecurrent.com/trials/glycaemic-alterations-in-icu-21265https://curecurrent.com/trials/effect-of-varying-the-protein-and-dietary-fiber-content-of-energy-bars-on-their-glycemic-and-insulinemic-impact-21266https://curecurrent.com/trials/psychoneuroimmunology-therapy-in-uncontrolled-diabetic-patients-a-quasi-experimental-study-21267https://curecurrent.com/trials/thiazolidinediones-or-sulphonylureas-and-cardiovascular-accidents-intervention-trial-21268https://curecurrent.com/trials/efficacy-and-safety-of-insulin-glargine-in-patients-with-type-2-diabetes-with-inadequate-control-on-dpp-4-inhibitor-ther-21269https://curecurrent.com/trials/a-post-marketing-safety-study-of-sitagliptin-januvia-mk-0431-234-21270https://curecurrent.com/trials/a-single-dose-study-of-mk6349-in-patients-with-type-2-diabetes-6349-002-21271https://curecurrent.com/trials/a-study-of-the-current-medical-practice-and-outcomes-in-the-treatment-of-type-2-diabetes-mellitus-in-an-office-setting-m-21272https://curecurrent.com/trials/clinical-trial-designed-to-determine-the-safety-and-efficacy-of-ema401-in-patients-with-painful-diabetic-neuropathy-21273https://curecurrent.com/trials/pearl-program-empowerment-program-for-patients-with-type-2-diabetes-hk4-21274https://curecurrent.com/trials/janumet-before-insulin-lantus-in-eastern-population-evaluation-program-jubilee-in-type-2-diabetic-patients-21275https://curecurrent.com/trials/effects-of-disease-management-on-development-of-end-stage-renal-disease-in-type-2-diabetic-patients-with-nephropathy-21276https://curecurrent.com/trials/the-effect-of-liraglutide-in-patients-with-prediabetes-and-kidney-failure-21277https://curecurrent.com/trials/treatment-with-erythropoietin-and-cognition-during-hypoglycaemia-21278https://curecurrent.com/trials/patient-experiences-with-injection-needles-21279https://curecurrent.com/trials/a-survey-to-evaluate-the-rate-of-abnormal-glucose-tolerance-among-hong-kong-chinese-subjects-with-coronary-heart-disease-21280https://curecurrent.com/trials/a-survey-on-the-rate-of-glucose-intolerance-in-hong-kong-chinese-21281https://curecurrent.com/trials/a-survey-to-evaluate-the-cardiovascular-risk-status-of-subjects-with-pre-diabetes-in-hong-kong-21282https://curecurrent.com/trials/prevalence-study-of-depression-in-chinese-patients-with-type-2-diabetes-hk13-21283https://curecurrent.com/trials/safety-efficacy-of-sitagliptin-in-patient-w-type-2-diabetes-0431-801-21284https://curecurrent.com/trials/bioavailability-of-a-fixed-dose-combination-tablet-with-empagliflozin-bi-10773-and-metformin-compared-with-the-monocompo-21285https://curecurrent.com/trials/alpha-lipoic-acid-reduces-left-ventricular-mass-in-normotensive-type-2-diabetic-patients-with-coronary-artery-disease-21286https://curecurrent.com/trials/evaluating-system-accuracy-and-user-performance-of-omnitest-blood-glucose-monitoring-systems-for-self-testing-in-managin-21287https://curecurrent.com/trials/hematopoietic-stem-cell-support-versus-insulin-in-t1d-21288https://curecurrent.com/trials/the-effects-of-atorvastatin-on-the-nitrogen-oxide-system-in-patients-with-type-2-diabetes-and-nephropathy-21289https://curecurrent.com/trials/surgical-treatment-in-diabetic-patients-with-grade-1-obesity-21290https://curecurrent.com/trials/comparison-of-glycaemic-fluctuation-and-oxidative-stress-between-two-short-term-therapies-for-type-2-diabetes-21291https://curecurrent.com/trials/post-marketing-surveillance-study-12-to-24-weeks-study-on-the-treatment-emergent-adverse-events-in-patients-with-type-2-21292https://curecurrent.com/trials/effects-of-curcumin-supplementation-on-lipid-profile-and-inflammatory-markers-of-patients-with-type-2-diabetes-21293https://curecurrent.com/trials/a-study-of-the-effects-of-sitagliptin-mk0431-and-metformin-on-incretin-hormone-concentrations-0431-050-completed-21294https://curecurrent.com/trials/metabolic-and-cardiovascular-effects-of-dipeptidyl-peptidase-4-dpp-4-or-sodium-glucose-co-transporter-type-2-sglt2-inhib-21295https://curecurrent.com/trials/a-study-on-the-effect-of-kidney-disease-on-a-diabetes-medication-0431-008-21296https://curecurrent.com/trials/effect-of-the-extract-of-the-flour-fermented-with-bacillus-subtilis-var-natto-dc-15-on-postprandial-glucose-21297https://curecurrent.com/trials/evaluation-of-continuous-glucose-monitoring-in-participants-with-type-2-diabetes-mellitus-mk-0000-258-am2-21298https://curecurrent.com/trials/a-study-of-mk-0893-on-glucagon-induced-glycemic-excursion-in-healthy-male-participants-following-intravenous-administrat-21299https://curecurrent.com/trials/study-of-the-bioequivalence-of-two-tablet-forms-of-mk0431-0431-027-21300https://curecurrent.com/trials/pioglitazone-regress-left-ventricular-mass-in-type-2-diabetes-with-ischeamia-heart-disease-21301https://curecurrent.com/trials/ocustem-nutritional-supplement-in-diabetic-patients-with-mild-to-moderate-non-proliferative-retinopathy-21302https://curecurrent.com/trials/an-open-label-multi-center-randomized-parallel-group-study-comparing-the-efficacy-and-safety-of-insulin-viaject-and-regu-21303https://curecurrent.com/trials/sitagliptin-reduces-left-ventricular-mass-in-normotensive-type-2-diabetic-patients-with-coronary-artery-disease-21304https://curecurrent.com/trials/effects-of-intranasal-oxytocin-and-vasopressin-on-social-behavior-and-decision-making-21305https://curecurrent.com/trials/the-effects-of-exenatide-on-oral-contraceptive-pharmacokinetics-in-healthy-females-21306https://curecurrent.com/trials/effects-of-rosiglitazone-and-metformin-on-metabolism-in-type-2-diabetes-21307https://curecurrent.com/trials/physical-activity-in-children-with-type-1-diabetes-study-21308https://curecurrent.com/trials/effect-of-atorvastatin-on-glycemic-control-in-prediabetic-patients-21309https://curecurrent.com/trials/effect-of-statin-treatment-on-urinary-aqp2-uaqp2-01-21310https://curecurrent.com/trials/safety-and-tolerability-efficacy-pharmacokinetic-and-pharmacodynamic-study-of-three-doses-of-bi-187004-over-28-days-in-p-21311https://curecurrent.com/trials/cold-stress-stimulate-the-browing-of-subcutaneous-white-adipose-in-healthy-adults-21312https://curecurrent.com/trials/sitagliptin-metformin-fed-bioequivalence-study-0431a-080-21313https://curecurrent.com/trials/3-month-trial-observation-of-a1c-change-21314https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-4-doses-of-imeglimin-after-24-weeks-of-treatment-in-subjects-with-type-2-diabetes-21315https://curecurrent.com/trials/study-to-identify-adequate-biomarker-to-detect-vitamin-b12-deficiency-in-type-2-diabetic-patients-treated-with-metformin-21316https://curecurrent.com/trials/perioperative-hyperglycaemia-in-primary-total-hip-and-knee-replacement-21317https://curecurrent.com/trials/a-post-marketing-safety-study-of-sitagliptin-phosphate-metformin-hydrochloride-janumet-mk-0431a-235-21318https://curecurrent.com/trials/evaluation-of-morbidities-endpoints-and-reaching-targets-in-diabetic-patients-managed-by-a-diabetes-specialist-team-21319https://curecurrent.com/trials/comparison-of-two-new-generation-drug-eluting-stents-in-patients-with-diabetes-oct-des-21320https://curecurrent.com/trials/importance-in-type-1-diabetes-patients-of-an-optimized-control-of-post-prandial-glycaemia-on-oxidant-stress-prevention-21321https://curecurrent.com/trials/syringes-replacement-for-insulin-application-for-pens-device-in-a-population-of-elderly-patients-with-type-2-diabetes-mu-21322https://curecurrent.com/trials/phenotypic-and-genetic-correlates-of-diabetes-non-type-1-in-young-non-obese-asian-indians-in-north-india-and-a-study-to-21323https://curecurrent.com/trials/paramedical-consultation-in-telemedicine-21324https://curecurrent.com/trials/empowerment-and-support-for-the-diabetic-patient-21325https://curecurrent.com/trials/human-adipose-derived-mesenchymal-stem-cells-for-critical-limb-ischemia-cli-in-diabetic-patients-21326https://curecurrent.com/trials/effect-of-diabetes-mellitus-on-success-of-spinal-anesthesia-21327https://curecurrent.com/trials/safety-and-tolerability-of-lixisenatide-in-combination-with-oral-anti-diabetic-treatment-in-patients-with-type-2-diabete-21328https://curecurrent.com/trials/effect-of-treatment-with-insulin-viajecttm-compared-to-regular-human-insulin-and-insulin-lispro-on-mealtime-blood-vessel-21329https://curecurrent.com/trials/an-evaluation-of-the-effectiveness-and-acceptability-of-delivering-structured-care-in-chinese-type-2-diabetic-patients-21330https://curecurrent.com/trials/an-open-label-multi-center-randomized-parallel-group-study-comparing-the-efficacy-and-safety-of-insulin-viaject-and-regu-21331https://curecurrent.com/trials/effects-of-an-exercise-program-among-cf-patients-with-dysglycemia-21332https://curecurrent.com/trials/electrical-stimulation-and-expression-of-vegf-vegfr-2-hif-and-no-in-the-diabetic-foot-ulcer-21333https://curecurrent.com/trials/askina-calgitrol-paste-diabetic-foot-ulcers-21334https://curecurrent.com/trials/metabolic-and-therapeutic-effects-of-american-and-korean-red-ginseng-in-the-treatment-of-type-2-diabetes-21335https://curecurrent.com/trials/skin-ulcers-treatment-with-an-handicraft-topical-device-21336https://curecurrent.com/trials/osteoprosis-in-type-2-diabetic-patients-a-cohort-study-21337https://curecurrent.com/trials/validation-of-the-artificial-pancreas-diabeloop-algorithm-in-the-hospital-21338https://curecurrent.com/trials/effect-of-soy-protein-and-polydextrose-on-food-intake-in-young-chinese-adult-males-21339https://curecurrent.com/trials/galvus-vildagliptin-vs-placebo-in-combination-with-metformin-and-insulin-21340https://curecurrent.com/trials/dexmedetomidine-affect-diabetic-patient-s-glucose-metabolism-21341https://curecurrent.com/trials/an-open-label-multi-center-follow-on-study-examining-the-long-term-safety-and-efficacy-of-insulin-viaject-in-subjects-wi-21342https://curecurrent.com/trials/an-open-label-multi-center-follow-on-study-examining-the-long-term-safety-and-efficacy-of-insulin-viaject-in-subjects-wi-21343https://curecurrent.com/trials/effectiveness-of-individualized-exercise-program-combined-with-a-balanced-diet-on-the-evolution-of-body-fat-21344https://curecurrent.com/trials/coronary-ct-angiography-in-asymptomatic-diabetes-mellitus-21345https://curecurrent.com/trials/a-study-evaluating-the-bioequivalence-of-viaject-7-compared-to-viaject-25-and-comparing-the-pharmacokinetic-and-pharmaco-21346https://curecurrent.com/trials/saxagliptin-s-effects-on-microalbuminuria-improvement-in-type-2-diabetic-patients-21347https://curecurrent.com/trials/the-effect-of-administration-of-small-doses-of-thyroxine-on-glucose-and-lipid-metabolism-in-type-2-diabetes-mellitus-21348https://curecurrent.com/trials/evaluation-of-low-blood-sugar-events-in-participants-with-diabetes-mk-0431-402-21349https://curecurrent.com/trials/metabolic-effects-of-accurate-blood-sugar-results-and-education-in-type-1-diabetes-21350https://curecurrent.com/trials/bioequivalence-study-of-sitagliptin-metformin-combination-tablet-mk0431a-122-21351https://curecurrent.com/trials/a-study-to-test-mk-0941-in-adults-with-type-2-diabetes-mellitus-with-inadequate-glycemic-control-on-insulin-mk-0941-018-21352https://curecurrent.com/trials/safety-study-to-assess-whether-proinsulin-peptide-injections-can-slow-or-stop-the-body-damaging-its-own-insulin-making-c-21353https://curecurrent.com/trials/duodenal-exclusion-for-the-treatment-of-type-2-diabetes-21354https://curecurrent.com/trials/a-study-of-single-dose-pain-therapy-in-patients-with-painful-diabetic-neuropathy-0000-115-21355https://curecurrent.com/trials/pharmacodynamic-and-pharmacokinetic-variability-of-a-basal-insulin-0000-168-21356https://curecurrent.com/trials/the-effects-of-jerusalem-artichoke-and-fermented-soybean-powder-mixture-supplementation-on-glucose-control-21357https://curecurrent.com/trials/effect-of-serving-size-and-addition-of-sugar-on-the-glycemic-response-elicited-by-oatmeal-21358https://curecurrent.com/trials/bladder-cancer-screening-among-diabetic-patients-21359https://curecurrent.com/trials/a-clinical-trial-to-investigate-safety-tolerability-and-pharmacokinetics-of-da-1229-01-evogliptin-metformin-xr-2-5-500-m-21360https://curecurrent.com/trials/the-significance-of-urine-uba52-in-the-diagnosis-of-diabetic-nephropathy-21361https://curecurrent.com/trials/the-effect-of-the-glp-1-receptor-agonists-on-blood-levels-of-lipoprotein-a-21362https://curecurrent.com/trials/effects-of-incretin-on-the-blood-pressure-and-lipid-in-patients-with-overweight-or-obese-diabetes-21363https://curecurrent.com/trials/comparative-effectiveness-of-two-approaches-to-diabetes-management-in-the-uninsured-21364https://curecurrent.com/trials/a-observational-study-to-evaluate-lipid-lowering-drug-its-effect-on-parameters-in-dyslipidemia-of-type-2-diabetes-21365https://curecurrent.com/trials/effect-of-dapagliflozine-on-systemic-and-renal-endothelial-function-21366https://curecurrent.com/trials/the-beta-cell-responsiveness-to-glucose-dependent-insulinotropic-polypeptide-gip-with-and-without-sulfonylurea-in-patien-21367https://curecurrent.com/trials/the-drug-drug-interaction-of-shr3824-and-metformin-21368https://curecurrent.com/trials/effect-of-gemigliptin-or-acarbose-on-endothelial-function-in-type-2-dm-patients-21369https://curecurrent.com/trials/an-investigational-drug-study-in-adults-with-type-2-diabetes-on-basal-insulin-mk-0941-006-21370https://curecurrent.com/trials/glucose-dependent-insulinotropic-polypeptide-new-role-as-blood-glucose-stabilizer-21371https://curecurrent.com/trials/gip-and-glp-1-in-type-1-diabetes-21372https://curecurrent.com/trials/investigating-efficacy-and-safety-of-biphasic-insulin-aspart-50-twice-daily-versus-biphasic-human-insulin-50-twice-daily-21373https://curecurrent.com/trials/to-compare-the-similarity-of-a-combination-dapagliflozin-metformin-tablet-with-the-two-drugs-administered-separately-21374https://curecurrent.com/trials/home-versus-hospital-care-in-glucose-monitoring-of-gestational-diabetes-and-mild-gestational-hyperglycemia-21375https://curecurrent.com/trials/efficacy-and-safety-of-lobeglitazone-versus-sitagliptin-21376https://curecurrent.com/trials/randomized-translational-study-to-examine-the-effects-of-shared-care-in-management-of-gestational-diabetes-21377https://curecurrent.com/trials/epidemiological-study-on-the-relationship-between-respiratory-health-and-air-pollution-from-industrial-sources-21378https://curecurrent.com/trials/remote-simultaneous-medical-interpreting-and-medical-outcomes-21379https://curecurrent.com/trials/a-study-of-absorption-metabolism-excretion-and-mass-balance-after-a-single-dose-administration-of-mk-0941-mk-0941-016-co-21380https://curecurrent.com/trials/monotherapy-study-in-patients-with-type-2-diabetes-mellitus-0431-021-21381https://curecurrent.com/trials/a-single-dose-crossover-study-of-mk0893-in-patients-with-type-2-diabetes-0893-019-am4-completed-21382https://curecurrent.com/trials/comparison-of-anesthetic-modalities-on-hemodynamic-stability-and-postoperative-pain-in-diabetic-foot-patients-undergoing-21383https://curecurrent.com/trials/sulfonylurea-add-on-study-in-patients-with-type-2-diabetes-mellitus-0431-035-21384https://curecurrent.com/trials/the-empowerment-model-towards-type-2-diabetic-adults-to-enhance-vegetable-intake-in-achieving-glycemic-control-21385https://curecurrent.com/trials/effectiveness-of-nigella-sativa-kalonji-seed-in-dyslipidemia-21386https://curecurrent.com/trials/multi-centre-peer-support-program-in-type-2-diabetes-patients-in-hong-kong-21387https://curecurrent.com/trials/multicomponent-telecare-model-for-supporting-prediabetes-patients-21388https://curecurrent.com/trials/assessment-of-blood-glucose-monitoring-systems-21389https://curecurrent.com/trials/the-phase-i-clinical-study-to-evaluate-the-pharmacokinetics-of-dw1029m-in-healthy-male-volunteer-21390https://curecurrent.com/trials/the-inhibitory-effect-of-metformin-on-gluconeogenesis-in-relation-to-polymorphisms-in-organic-cation-transporter-1-21391https://curecurrent.com/trials/the-role-of-small-intestinal-endocrine-cells-in-type-2-diabetic-hyperglucagonemia-21392https://curecurrent.com/trials/telemonitoring-system-study-in-participants-with-type-2-diabetes-mellitus-mk-0000-347-21393https://curecurrent.com/trials/community-health-assessment-program-in-the-philippines-21394https://curecurrent.com/trials/effectiveness-of-a-treat-to-target-clinic-led-by-a-nurse-consultants-21395https://curecurrent.com/trials/efficacy-and-tolerability-of-mk0533-in-patients-with-type-2-diabetes-0533-005-21396https://curecurrent.com/trials/sustained-effects-of-a-non-glucidic-nutrient-preload-on-glucose-tolerance-in-type-2-diabetes-21397https://curecurrent.com/trials/regulatory-t-cells-in-type-1-diabetes-patients-treated-with-il-2-21398https://curecurrent.com/trials/mk0767-added-to-insulin-therapy-in-patients-with-type-2-diabetes-0767-030-21399https://curecurrent.com/trials/clinical-evaluation-of-daptomycin-bone-penetration-21400https://curecurrent.com/trials/consequences-of-human-inactivity-21401https://curecurrent.com/trials/incretin-effect-and-use-after-clinical-islet-transplantation-21402https://curecurrent.com/trials/a-study-to-evaluate-azp531-in-healthy-volunteers-overweight-obese-volunteers-and-patients-with-type-2-diabetes-mellitus-21403https://curecurrent.com/trials/analytical-performance-evaluation-of-blood-glucose-monitoring-systems-investigator-sponsored-contour-xt-comparator-study-21404https://curecurrent.com/trials/effects-on-exercise-hemodynamics-of-vasopressin-blockade-by-conivaptan-infusion-in-heart-failure-patients-21405https://curecurrent.com/trials/autologous-endothelial-progenitor-cells-treatment-of-diabetic-foot-21406https://curecurrent.com/trials/placebo-controlled-metformin-and-sulfonylurea-combination-study-in-patients-with-type-2-diabetes-0767-025-21407https://curecurrent.com/trials/mk0767-and-metformin-combination-study-0767-028-21408https://curecurrent.com/trials/functional-ingredients-effect-in-gastrointestinal-system-21409https://curecurrent.com/trials/the-relation-between-plasma-irisin-level-and-endothelial-dysfunction-in-type-2-diabetes-21410https://curecurrent.com/trials/changes-of-endothelial-function-before-and-after-dsa-in-patients-with-diabetes-21411https://curecurrent.com/trials/minimal-psychological-intervention-in-diabetes-patients-21412https://curecurrent.com/trials/atp-release-and-sympathetic-nerve-activity-in-patients-with-type-ii-diabetes-21413https://curecurrent.com/trials/effectiveness-of-a-computerised-prompt-for-primary-and-secondary-care-physicians-to-refer-or-refer-back-type-2-diabetes-21414https://curecurrent.com/trials/mk0767-in-type-2-diabetes-0767-012-21415https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-exenatide-once-weekly-injection-compared-to-once-daily-insulin-in-type-2-di-21416https://curecurrent.com/trials/assessment-of-the-efficacy-and-safety-of-lixisenatide-in-patients-with-type-2-diabetes-insufficiently-controlled-with-ba-21417https://curecurrent.com/trials/the-effect-of-spinal-anesthesia-on-heart-rate-variability-in-diabetic-patients-21418https://curecurrent.com/trials/mk0431-monotherapy-study-in-patients-with-type-2-diabetes-mellitus-0431-040-21419https://curecurrent.com/trials/a-study-of-an-investigational-drug-sitagliptin-for-type-2-diabetes-mellitus-0431-044-21420https://curecurrent.com/trials/study-mk0767-and-metformin-in-type-2-diabetic-patients-0767-020-21421https://curecurrent.com/trials/mk0767-glipizide-comparator-cardiac-safety-study-0767-018-21422https://curecurrent.com/trials/haptoglobin-phenotype-and-cardiovascular-complications-in-diabetic-patients-21423https://curecurrent.com/trials/dyslipidemia-in-type-2-diabetes-0767-034-21424https://curecurrent.com/trials/evaluating-safety-of-novopen-3-and-or-flexpen-devices-in-routine-clinical-practice-21425https://curecurrent.com/trials/mk0767-and-sulfonylurea-combination-study-0767-027-21426https://curecurrent.com/trials/acceptability-and-feasibility-of-an-act-based-group-to-improve-diabetes-self-management-21427https://curecurrent.com/trials/effect-of-iron-reduction-by-phlebotomy-for-type-2-diabetes-21428https://curecurrent.com/trials/bioequivalence-food-effect-saxa-dapa-dual-fixed-dose-combination-fdc-21429https://curecurrent.com/trials/coronary-artery-calcification-in-type-1-diabetes-21430https://curecurrent.com/trials/the-effects-of-antecedent-hypoglycemia-or-exercise-on-the-response-of-the-brain-to-subsequent-hypoglycemia-21431https://curecurrent.com/trials/a-study-to-demonstrate-the-bioequivalence-of-sitagliptin-metformin-combination-tablets-and-co-administration-of-sitaglip-21432https://curecurrent.com/trials/therapeutic-efficacy-of-abroma-agusta-in-hba1c-in-niddm-21433https://curecurrent.com/trials/the-role-of-vitamin-d3-and-calcium-supplementation-in-attenuating-t2dm-severity-21434https://curecurrent.com/trials/closing-the-loop-in-adults-with-sub-optimally-controlled-type-1-diabetes-under-free-living-conditions-21435https://curecurrent.com/trials/efficacy-of-higher-cutting-rate-in-microincision-vitrectomy-for-proliferative-diabetic-retinopathy-21436https://curecurrent.com/trials/intravitreal-bevacizumab-avastin-versus-intravitreal-dexamethasone-ozurdex-for-persistent-diabetic-macular-oedema-21437https://curecurrent.com/trials/the-effect-of-glp-1-receptor-activation-on-central-reward-and-satiety-in-obesity-and-diabetes-21438https://curecurrent.com/trials/low-level-laser-therapy-and-expression-of-vegf-no-vegfr-2-hif-1-in-diabetic-foot-ulcers-21439https://curecurrent.com/trials/effect-of-exercise-on-risk-factors-of-elderly-women-21440https://curecurrent.com/trials/investigation-of-the-pharmacokinetic-properties-of-biphasic-insulin-aspart-50-in-healthy-chinese-subjects-21441https://curecurrent.com/trials/a-trial-investigating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-nnc0148-0000-0362-in-healthy-subj-21442https://curecurrent.com/trials/the-effects-of-physical-training-and-glp-1-receptor-agonist-liraglutide-treatment-in-patients-with-type-2-diabetes-21443https://curecurrent.com/trials/retreatment-of-chronic-hepatitis-c-non-responders-with-pegylated-interferon-alpha-plus-ribavirin-plus-pioglitazone-21444https://curecurrent.com/trials/elevated-ffa-and-skeletal-muscle-lipid-content-21445https://curecurrent.com/trials/cardiovascular-risk-factor-management-in-hiv-infection-21446https://curecurrent.com/trials/markers-of-bone-status-in-diabetes-mellitus-type-1-and-type-2-21447https://curecurrent.com/trials/understanding-and-appraising-the-new-medicine-service-in-england-21448https://curecurrent.com/trials/atorvastatin-aspirin-oxidative-stress-coagulation-and-platelet-activation-indexes-21449https://curecurrent.com/trials/the-use-of-a-community-based-organization-to-change-lifestyle-characteristics-related-to-non-communicable-diseases-21450https://curecurrent.com/trials/meta-analysis-of-fructose-containing-sugar-sweetened-beverages-ssbs-and-weight-change-21451https://curecurrent.com/trials/comparison-of-resin-salve-and-octenidine-in-patients-with-neuropathic-diabetic-foot-ulcers-21452https://curecurrent.com/trials/meta-analyses-of-the-effect-of-dietary-pulses-on-acute-postprandial-metabolic-control-21453https://curecurrent.com/trials/meta-analyses-of-the-effect-of-tree-nuts-on-glycemic-control-and-features-of-the-metabolic-syndrome-21454https://curecurrent.com/trials/metformin-in-gestational-diabetes-mellitus-21455https://curecurrent.com/trials/meta-analyses-of-fructose-and-cardiometabolic-risk-21456https://curecurrent.com/trials/infants-of-diabetic-mothers-a-cohort-study-21457https://curecurrent.com/trials/the-medicines-advice-service-evaluation-21458https://curecurrent.com/trials/a-study-of-ly2189265-in-japanese-participants-with-type-2-diabetes-mellitus-21459https://curecurrent.com/trials/evaluation-of-stendo-pulsating-suit-on-microcirculation-and-endothelial-function-in-diabetic-patients-21460https://curecurrent.com/trials/the-mobile-diabetes-mgmt-study-with-type-2-diabetes-21461https://curecurrent.com/trials/follow-up-study-of-complications-of-acute-pancreatitis-21462https://curecurrent.com/trials/mk0916-in-patients-with-type-2-diabetes-and-metabolic-syndrome-0916-005-21463https://curecurrent.com/trials/comparison-of-insulin-mix25-versus-mix50-21464https://curecurrent.com/trials/retrospective-collection-of-effectiveness-and-safety-data-from-patients-treated-with-liraglutide-or-dpp-4-inhibitor-in-p-21465https://curecurrent.com/trials/pharmaceutical-care-in-emergency-department-21466https://curecurrent.com/trials/aliskiren-vs-hydrochlorothiazide-in-hypertensive-type-ii-diabetic-patients-on-resistance-arteries-21467https://curecurrent.com/trials/losartan-versus-hydrochlorothiazide-in-reversing-remodeling-of-small-arteries-in-pre-hypertensive-pre-diabetic-subjects-21468https://curecurrent.com/trials/progression-of-coronary-atherosclerosis-in-asymptomatic-diabetic-subjects-21469https://curecurrent.com/trials/study-to-evaluate-safety-and-efficacy-of-precrea-on-subjects-with-higher-than-normal-blood-sugar-levels-21470https://curecurrent.com/trials/dynamic-responsiveness-of-insulin-secretory-parameters-to-sitagliptin-and-glimeperide-administration-in-type-2-dm-21471https://curecurrent.com/trials/beta-cell-function-and-related-pharmacodynamics-of-hms5552-in-t2dm-patients-21472https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-isis-gccrrx-in-type-2-diabetes-21473https://curecurrent.com/trials/metabolic-effects-of-the-manipulation-of-nutrient-sequence-in-the-main-meals-in-type-2-diabetic-patients-21474https://curecurrent.com/trials/effects-of-low-intensity-aerobic-exercise-on-the-microvascular-endothelial-function-of-patients-with-type-1-diabetes-21475https://curecurrent.com/trials/the-impact-of-post-discharge-one-time-home-visit-bridging-the-gap-between-hospital-and-home-21476https://curecurrent.com/trials/myocardial-metabolism-in-patients-with-dilated-cardiomyopathy-21477https://curecurrent.com/trials/the-effect-of-antecedent-hypoglycaemia-on-2-adrenergic-sensitivity-21478https://curecurrent.com/trials/the-efficacy-of-acarbose-and-metformin-on-blood-glucose-fluctuation-when-combined-with-premix-insulin-21479https://curecurrent.com/trials/bioequivalence-study-of-fixed-dose-combinations-and-coadministered-individual-tablets-of-saxagliptin-metformin-brazil-21480https://curecurrent.com/trials/an-intervention-to-improve-management-of-dyslipidemia-in-primary-care-21481https://curecurrent.com/trials/locally-delivered-aloe-vera-gel-in-the-treatment-of-chronic-periodontitis-patients-with-diabetes-mellitus-21482https://curecurrent.com/trials/neuropathic-pain-syndrome-patient-study-mk-0000-072-21483https://curecurrent.com/trials/the-expert-system-voicediab-in-children-with-diabetes-21484https://curecurrent.com/trials/mobile-unit-screening-of-pathologies-associated-with-chronic-diseases-feasibility-21485https://curecurrent.com/trials/neurogenic-inflammation-in-diabetes-21486https://curecurrent.com/trials/the-effect-of-yogurt-enriched-with-flaxseed-on-cardiovascular-risk-factors-in-type-2-diabetic-patients-21487https://curecurrent.com/trials/the-effect-of-whey-protein-consumed-as-a-pre-meal-on-postprandial-lipemia-in-healthy-and-subjects-with-type-2-diabetes-21488https://curecurrent.com/trials/the-effect-of-protein-quality-and-time-factor-by-consumption-of-a-pre-meal-on-postprandial-lipemia-in-subjects-with-the-21489https://curecurrent.com/trials/vascular-reactivity-in-kidney-disease-patients-21490https://curecurrent.com/trials/safety-and-efficacy-of-insulin-nph-compared-to-a-new-insulin-formulation-in-subjects-with-type-2-diabetes-21491https://curecurrent.com/trials/closed-loop-control-of-glucose-levels-artificial-pancreas-during-exercise-in-adults-with-type-1-diabetes-21492https://curecurrent.com/trials/closed-loop-control-of-glucose-levels-artificial-pancreas-for-60-hours-in-adults-with-type-1-diabetes-21493https://curecurrent.com/trials/a-phase-2-study-exploring-the-safety-and-efficacy-of-novel-drug-treatment-in-subjects-with-diabetic-macular-edema-dme-21494https://curecurrent.com/trials/comparison-of-a-plant-protein-diet-to-a-animal-protein-diet-emphasized-in-type-2-diabetics-21495https://curecurrent.com/trials/gestational-diabetes-induction-versus-expectant-management-of-labour-21496https://curecurrent.com/trials/mobile-phone-personalized-intervention-for-diabetes-21497https://curecurrent.com/trials/bioequivalence-of-two-insulatard-formulations-in-healthy-subjects-21498https://curecurrent.com/trials/continuous-glucose-sensing-at-the-site-of-subcutaneous-insulin-administration-21499https://curecurrent.com/trials/efficacy-and-safety-of-v0111-cream-on-open-cracked-heel-in-diabetic-patients-with-polyneuropathy-21500https://curecurrent.com/trials/study-to-compare-the-efficacy-and-safety-of-administration-of-the-fix-dose-combination-of-linagliptin-plus-metformin-in-21501https://curecurrent.com/trials/efficacy-of-spironolactone-in-cameroonian-diabetic-patients-with-resistant-hypertension-21502https://curecurrent.com/trials/comparison-of-pioglitazone-versus-glimepiride-in-type-2-diabetes-inadequately-controlled-with-metformin-plus-alogliptin-21503https://curecurrent.com/trials/contribution-of-nuclear-magnetic-resonance-imaging-in-the-study-of-diabetic-cardiomyopathy-21504https://curecurrent.com/trials/metabolic-clock-genes-during-fasting-and-after-food-intake-in-type-2-diabetics-21505https://curecurrent.com/trials/study-of-effectiveness-of-telemedicine-in-identifying-diabetic-retinopathy-cases-21506https://curecurrent.com/trials/estimation-of-glomerular-filtration-rate-gfr-in-patients-with-type-2-diabetes-mellitus-21507https://curecurrent.com/trials/the-obstacle-hypoglycemia-study-mk-0000-158-21508https://curecurrent.com/trials/arginase-inhibition-in-ischemia-reperfusion-injury-21509https://curecurrent.com/trials/effects-of-vitamin-d-supplementation-in-subjects-with-new-onset-of-type-1-diabetes-21510https://curecurrent.com/trials/the-impact-of-rosuvastatin-on-the-density-score-of-coronary-artery-calcification-in-cad-patients-with-diabetes-mellitus-21511https://curecurrent.com/trials/dpp-iv-inhibition-prior-to-development-of-diabetes-in-patients-with-cystic-fibrosis-21512https://curecurrent.com/trials/md-logic-artificial-pancreas-for-automatic-type-1-diabetes-meals-management-21513https://curecurrent.com/trials/screening-and-understanding-of-the-pre-diabetes-decodiab-21514https://curecurrent.com/trials/durban-diabetes-study-a-study-of-the-epidemiology-of-diabetes-mellitus-in-urban-south-africans-of-african-descent-dds-21515https://curecurrent.com/trials/bevacizumab-versus-ranibizumab-for-diabetic-retinopathy-21516https://curecurrent.com/trials/safety-and-efficacy-of-biphasic-human-insulin-compared-to-ex1000-in-type-2-diabetes-21517https://curecurrent.com/trials/markers-and-mechanisms-of-macrovascular-disease-in-iddm-21518https://curecurrent.com/trials/effect-of-pioglitazone-on-left-ventricular-diastolic-function-in-type-2-diabetes-mellitus-21519https://curecurrent.com/trials/functional-mri-biomarkers-of-cognitive-decrements-in-diabetes-21520https://curecurrent.com/trials/interactive-tool-to-support-self-management-through-lifestyle-feedback-aimed-at-physical-activity-of-copd-dm-patients-21521https://curecurrent.com/trials/safety-and-tolerability-of-lixisenatide-in-monotherapy-in-patients-with-type-2-diabetes-21522https://curecurrent.com/trials/renal-and-systemic-effects-of-ncx4016-in-patients-with-type-2-diabetes-and-early-nephropathy-21523https://curecurrent.com/trials/safety-and-efficacy-of-exenatide-once-weekly-versus-liraglutide-in-subjects-with-type-2-diabetes-21524https://curecurrent.com/trials/choice-changes-to-treatment-and-outcomes-in-patients-with-type-2-diabetes-initiating-injectable-therapy-21525https://curecurrent.com/trials/effectiveness-and-safety-of-early-stage-amputation-and-external-herbs-chitosan-for-diabetic-foot-ulcer-21526https://curecurrent.com/trials/a-survey-on-hypoglycaemia-among-insulin-treated-patients-with-diabetes-21527https://curecurrent.com/trials/exenatide-and-basal-insulins-use-in-the-real-setting-an-observational-study-in-patients-with-type-2-diabetes-21528https://curecurrent.com/trials/a-comparison-of-adding-exenatide-with-switching-to-exenatide-in-patients-with-type-2-diabetes-experiencing-inadequate-gl-21529https://curecurrent.com/trials/a-study-to-examine-the-effects-of-exenatide-once-weekly-injection-on-glucose-control-and-safety-in-asian-subjects-21530https://curecurrent.com/trials/efficacy-and-safety-of-exenatide-in-japanese-patients-with-type-2-diabetes-who-are-treated-with-oral-antidiabetic-s-21531https://curecurrent.com/trials/delapril-and-manidipine-for-nephroprotection-in-diabetes-demand-21532https://curecurrent.com/trials/renal-effect-of-pentoxyphylline-in-high-risk-patients-undergoing-angiography-21533https://curecurrent.com/trials/desmopressin-as-treatment-for-postoperative-bleeding-after-cardiac-surgery-21534https://curecurrent.com/trials/breakfast-on-postprandial-hyperglycemia-21535https://curecurrent.com/trials/non-surgical-periodontal-therapy-effects-metabolic-control-in-diabetics-21536https://curecurrent.com/trials/empagliflozin-add-on-to-insulin-in-type-1-diabetes-mellitus-over-28-days-21537https://curecurrent.com/trials/community-based-multiple-risk-factors-intervention-strategy-21538https://curecurrent.com/trials/effects-of-exenatide-and-insulin-glargine-in-subjects-with-type-2-diabetes-21539https://curecurrent.com/trials/an-exploratory-study-of-the-effect-of-treatment-interruption-on-safety-of-exenatide-in-patients-with-type-2-diabetes-21540https://curecurrent.com/trials/a-trial-comparing-two-therapies-basal-insulin-glargine-exenatide-and-metformin-therapy-bet-or-basal-insulin-glargine-bol-21541https://curecurrent.com/trials/evaluation-of-retinal-changes-in-systemic-darbepoetin-alpha-treatment-in-patients-with-diabetes-mellitus-21542https://curecurrent.com/trials/effect-of-exenatide-plus-metformin-vs-insulin-aspart-plus-metformin-on-glycemic-control-and-hypoglycemia-in-patients-wit-21543https://curecurrent.com/trials/double-blind-placebo-study-of-jardiance-empagliflozin-in-prehypertensives-type-ii-diabetics-21544https://curecurrent.com/trials/metabolic-effects-of-gh-and-igf-i-in-growth-hormone-deficient-ghd-and-diabetes-and-impaired-glucose-tolerance-igt-21545https://curecurrent.com/trials/exenatide-compared-with-twice-daily-biphasic-insulin-aspart-in-patients-with-type-2-diabetes-using-sulfonylurea-and-metf-21546https://curecurrent.com/trials/efficacy-of-once-weekly-exenatide-versus-once-or-twice-daily-insulin-detemir-in-patients-with-type-2-diabetes-21547https://curecurrent.com/trials/incidence-of-hypoglycemia-during-ramadan-in-patients-with-type1-diabetes-on-insulin-pump-versus-multi-dose-injection-21548https://curecurrent.com/trials/a-study-comparing-exenatide-with-basal-insulin-in-achieving-a-target-hba1c-with-minimum-weight-gain-in-type-2-diabetes-p-21549https://curecurrent.com/trials/a-study-to-assess-the-effect-of-exenatide-treatment-on-mean-24-hour-heart-rate-in-patients-with-type-2-diabetes-21550https://curecurrent.com/trials/post-marketing-surveillance-for-hypertensive-patients-with-diabetes-and-or-chronic-kidney-disease-21551https://curecurrent.com/trials/effect-of-dexamethasone-implant-in-hard-exudate-complicated-with-diabetic-macular-edema-21552https://curecurrent.com/trials/effects-of-fenofibrate-on-metabolic-and-reproductive-parameters-in-polycystic-ovary-syndrome-21553https://curecurrent.com/trials/study-of-multiple-doses-of-saxagliptin-bms-477118-21554https://curecurrent.com/trials/phase-iii-trial-to-evaluate-the-efficacy-and-safety-of-initial-combination-therapy-with-gemigliptin-50mg-q-d-and-metform-21555https://curecurrent.com/trials/effects-of-jeju-red-horsehead-fish-based-high-protein-diet-on-satiety-and-incretin-hormones-in-diabetes-patients-21556https://curecurrent.com/trials/an-investigational-drug-in-patients-with-type-2-diabetes-mellitus-and-chronic-renal-insufficiency-0431-028-completed-21557https://curecurrent.com/trials/effects-of-pioglitazone-in-type-2-diabetes-mellitus-and-coronary-heart-disease-21558https://curecurrent.com/trials/liraglutide-as-add-on-to-insulin-in-type-1-diabetes-21559https://curecurrent.com/trials/genetic-susceptibility-factor-as-a-predictor-of-type-2-diabetes-remission-and-weight-loss-after-bariatric-surgery-21560https://curecurrent.com/trials/a-comparison-of-strict-glucose-control-with-usual-care-at-the-time-of-islet-cell-transplantation-21561https://curecurrent.com/trials/does-vitamin-d-improve-glycemic-control-in-type-ii-dm-21562https://curecurrent.com/trials/the-impact-of-the-glycaemic-index-gi-on-daily-blood-glucose-profiles-and-food-intake-in-young-chinese-adult-males-21563https://curecurrent.com/trials/pleiotropic-effects-of-azilsartan-medoxomil-over-insulin-resistance-in-obese-diabetic-and-hypertensive-patients-21564https://curecurrent.com/trials/efficacy-and-safety-of-dapagliflozin-in-combination-with-metformin-in-type-2-diabetes-patients-21565https://curecurrent.com/trials/influence-of-regular-exercise-and-detraining-on-metabolic-and-emotional-parameters-in-diabetic-individuals-21566https://curecurrent.com/trials/substituting-brown-rice-for-white-rice-effect-on-diabetes-risk-factors-in-india-21567https://curecurrent.com/trials/study-of-comparison-the-treatment-effect-between-gastric-bypass-and-exenatide-in-type-2-diabetes-21568https://curecurrent.com/trials/feasibility-study-to-determine-the-optimal-calibration-method-for-glucose-sensors-21569https://curecurrent.com/trials/wound-healing-process-in-diabetic-neuropathy-and-diabetic-neuroischemia-21570https://curecurrent.com/trials/ontario-printed-educational-materials-pems-for-physician-behaviour-change-21571https://curecurrent.com/trials/comparison-of-liraglutide-inhaled-into-the-lungs-compared-to-liraglutide-injected-under-the-skin-in-healthy-male-volunte-21572https://curecurrent.com/trials/treatment-of-low-blood-sugar-with-glucagon-among-patients-with-type-1-diabetes-21573https://curecurrent.com/trials/randomized-study-of-intravenous-immunoglobulin-ivig-in-patients-with-subacute-proximal-diabetic-neuropathy-21574https://curecurrent.com/trials/medical-nutrition-therapy-plus-transgestational-metformin-for-preventing-gestational-diabetes-in-high-risk-mexican-women-21575https://curecurrent.com/trials/pet-ct-scanning-for-the-follow-up-of-antibiotic-treatment-of-infectious-osteoarthritis-in-the-diabetic-foot-21576https://curecurrent.com/trials/blood-pressure-outcomes-with-liraglutide-therapy-21577https://curecurrent.com/trials/trendy-follow-up-study-on-endothelial-function-in-subjects-with-type-2-diabetes-mellitus-21578https://curecurrent.com/trials/exercise-in-type-1-diabetes-mellitus-21579https://curecurrent.com/trials/glyburide-and-metformin-for-the-treatment-of-gestational-diabetes-mellitus-systematic-review-21580https://curecurrent.com/trials/laser-versus-vitrectomy-versus-intravitreal-triamcinolone-injection-for-diabetic-macular-edema-21581https://curecurrent.com/trials/effect-of-quercetin-supplements-on-healthy-males-a-four-week-randomized-cross-over-trial-21582https://curecurrent.com/trials/comparison-of-repaglinide-and-metformin-combination-tablet-versus-repaglinide-and-metformin-as-separate-tablets-in-healt-21583https://curecurrent.com/trials/endobarrier-versus-intragastric-balloon-in-obese-diabetic-patients-21584https://curecurrent.com/trials/cpap-in-diabetes-type-2-patients-with-sleep-apnea-21585https://curecurrent.com/trials/phase-i-multiple-ascending-dose-japan-21586https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetics-food-effect-of-mk-0941-in-adults-with-type-2-diabetes-mk-0941-009-21587https://curecurrent.com/trials/efficacy-of-dorzolamide-as-an-adjuvant-after-focal-photocoagulation-in-clinically-significant-macular-edema-21588https://curecurrent.com/trials/eeg-changes-of-type1-diabetes-during-sleep-insulin-induced-hypoglycemia-21589https://curecurrent.com/trials/topic-antiinflammatory-therapy-added-to-selective-photocoagulation-in-macular-edema-21590https://curecurrent.com/trials/effect-of-coadministration-of-ume-paste-prunus-mume-and-ginger-powder-21591https://curecurrent.com/trials/prospective-randomized-open-label-phase-ii-study-to-assess-efficacy-and-safety-of-macugen-pegaptanib-0-3-mg-intravitreal-21592https://curecurrent.com/trials/inpatient-evaluation-of-the-md-logic-artificial-pancreas-system-in-patients-with-type-1-diabetes-21593https://curecurrent.com/trials/open-label-study-to-evaluate-long-term-treatment-effect-of-diapep277-21594https://curecurrent.com/trials/bioequivalence-of-two-mixtard-30-formulations-in-healthy-subjects-21595https://curecurrent.com/trials/study-to-test-software-algorithm-for-insulin-therapy-and-new-glucose-sensor-21596https://curecurrent.com/trials/effect-of-omega-3-fatty-acids-on-insulin-sensitivity-in-chinese-type-2-diabetic-patients-21597https://curecurrent.com/trials/roles-of-t-helper-1-cytokines-in-type-1-diabetes-21598https://curecurrent.com/trials/impact-of-individualized-structured-information-provision-to-the-patients-on-diabetes-related-outcomes-21599https://curecurrent.com/trials/neuragen-for-peripheral-diabetic-neuropathy-21600https://curecurrent.com/trials/open-label-investigation-of-the-safety-and-efficacy-of-diabecell-in-patients-with-type-1-diabetes-mellitus-21601https://curecurrent.com/trials/lipid-lowering-with-highly-potent-statins-in-hyperlipidaemia-with-type-2-diabetes-patients-21602https://curecurrent.com/trials/impact-of-elka-the-toolset-for-food-exchanges-calculation-on-metabolic-control-in-pediatric-diabetic-patients-21603https://curecurrent.com/trials/prevalence-and-risk-factors-of-erectile-dysfunction-in-type-2-diabetic-patients-21604https://curecurrent.com/trials/weight-trajectory-in-new-users-of-sulfonylureas-as-add-on-therapy-next-to-metformin-21605https://curecurrent.com/trials/effects-of-gemigliptin-versus-sitagliptin-or-glimepiride-with-metformin-on-glucose-variability-mage-glucose-sd-patients-21606https://curecurrent.com/trials/urokinase-therapy-in-patients-with-diabetic-foot-syndrome-21607https://curecurrent.com/trials/study-on-exploring-the-effect-of-dpp-4-inhibitors-on-cell-function-by-using-the-two-step-hyperglycemic-clamp-21608https://curecurrent.com/trials/behavioral-lifestyle-intervention-study-blis-in-patients-with-type-2-diabetes-in-uae-a-randomized-controlled-trial-in-re-21609https://curecurrent.com/trials/mk-0941-multiple-dose-study-in-japanese-patients-with-type-2-diabetes-mk-0941-011-21610https://curecurrent.com/trials/accu-chek-combo-in-young-patients-21611https://curecurrent.com/trials/maximising-the-taste-and-health-value-of-plant-food-products-21612https://curecurrent.com/trials/retinal-function-in-relation-to-transient-or-chronic-challenges-to-retinal-metabolism-21613https://curecurrent.com/trials/aloe-vera-in-chronic-periodontitis-with-type-2-diabetes-mellitus-21614https://curecurrent.com/trials/retinal-adaptation-to-intensified-insulin-therapy-and-bariatric-surgery-in-patients-with-diabetes-21615https://curecurrent.com/trials/effect-of-short-term-intensive-insulin-sequential-exenatide-therapy-in-newly-diagnosed-type-2-diabetic-patients-21616https://curecurrent.com/trials/prevention-of-hypoglycaemia-with-predictive-insulin-suspend-using-sensor-augmented-insulin-pump-in-children-21617https://curecurrent.com/trials/effect-of-low-gi-glycemic-load-gl-diet-in-diabetic-nephropathy-patients-21618https://curecurrent.com/trials/long-term-mortality-in-diabetics-undergoing-major-surgery-21619https://curecurrent.com/trials/effects-of-low-or-high-glycemic-index-diets-on-metabolic-and-inflammatory-responses-in-diabetics-21620https://curecurrent.com/trials/a-pharmacokinetic-study-of-mk-0941-after-multiple-daily-doses-in-subjects-with-type-2-diabetes-mk-0941-012-completed-21621https://curecurrent.com/trials/changing-diabetes-in-children-21622https://curecurrent.com/trials/sitagliptin-metformin-janumet-re-examination-study-0431a-182-21623https://curecurrent.com/trials/optimized-glycemic-control-in-heart-failure-patients-with-dm2-effect-on-left-ventricular-function-and-skeletal-muscle-21624https://curecurrent.com/trials/partnership-for-a-hispanic-diabetes-prevention-program-21625https://curecurrent.com/trials/bone-marrow-as-an-alternative-site-for-islet-transplantation-21626https://curecurrent.com/trials/efficacy-safety-of-pedyphar-ointment-in-diabetic-foot-ulcer-treatment-21627https://curecurrent.com/trials/establishing-a-diabetes-registry-using-the-jade-diamond-electronic-portal-cn001-21628https://curecurrent.com/trials/safety-study-of-multigeneangio-in-patients-with-chronic-critical-limb-ischemia-21629https://curecurrent.com/trials/a-trial-investigating-the-pharmacodynamic-and-pharmacokinetic-properties-of-insulin-degludec-insulin-aspart-15-in-subjec-21630https://curecurrent.com/trials/comparing-the-efficacy-and-safety-of-biphasic-insulin-aspart-30-and-biphasic-human-insulin-30-on-blood-sugar-control-in-21631https://curecurrent.com/trials/adipocytokines-gestational-diabetes-mellitus-and-lipid-metabolism-21632https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-isis-ptp1brx-in-type-2-diabetes-21633https://curecurrent.com/trials/the-cycle-study-a-study-of-the-effectiveness-of-cycling-exercise-in-breaking-the-cycle-of-pregnancy-diabetes-21634https://curecurrent.com/trials/a-single-dose-study-to-investigate-the-pharmacokinetics-of-mk-0941-in-participants-with-renal-insufficiency-mk-0941-015-21635https://curecurrent.com/trials/diet-and-exercise-in-type-2-diabetes-a-randomized-controlled-trial-21636https://curecurrent.com/trials/safety-and-efficacy-study-of-bc-dn-01-in-painful-diabetic-peripheral-neuropathy-21637https://curecurrent.com/trials/fish-oil-supplementation-in-women-with-gestational-diabetes-21638https://curecurrent.com/trials/a-study-to-examine-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-exenatide-once-weekly-in-japanese-patien-21639https://curecurrent.com/trials/a-clinical-trial-investigating-the-comparison-of-three-different-concentrations-of-nn9535-in-healthy-male-subjects-21640https://curecurrent.com/trials/investigation-on-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-nn9924-in-healthy-male-subjects-21641https://curecurrent.com/trials/study-of-efficacy-and-safety-lmf237-in-patients-with-type-2-diabetes-mellitus-t2dm-inadequately-controlled-with-vildagli-21642https://curecurrent.com/trials/safety-and-efficacy-of-exenatide-in-patients-with-type-2-diabetes-using-metformin-or-sulfonylureas-and-metformin-21643https://curecurrent.com/trials/a-trial-investigating-the-pharmacokinetic-properties-of-formulations-of-nn1218-in-subjects-with-type-1-diabetes-21644https://curecurrent.com/trials/safety-tolerability-and-profile-of-action-of-drug-in-the-body-of-nn9535-in-healthy-male-japanese-and-caucasian-subjects-21645https://curecurrent.com/trials/comparing-exenatide-and-insulin-glargine-in-type-2-diabetes-patients-for-whom-insulin-is-the-next-appropriate-therapy-21646https://curecurrent.com/trials/comparison-of-exenatide-taken-before-lunch-and-dinner-with-before-breakfast-and-dinner-in-patients-with-type-2-diabetes-21647https://curecurrent.com/trials/matrix-metalloproteinases-in-atherosclerosis-of-chronic-kidney-disease-21648https://curecurrent.com/trials/a-trial-investigating-the-pharmacokinetic-properties-of-nn1218-in-subjects-with-diabetes-mellitus-type-1-21649https://curecurrent.com/trials/a-study-to-assess-the-effect-on-glucose-control-and-safety-and-tolerability-of-ly2148568-in-japanese-patients-with-type-21650https://curecurrent.com/trials/pharmacoscintigraphic-investigation-of-nn9924-in-healthy-male-subjects-21651https://curecurrent.com/trials/a-trial-to-test-for-bioequivalence-between-nn1045-and-nn5401-in-subjects-with-type-1-diabetes-21652https://curecurrent.com/trials/a-study-by-scintigraphy-to-evaluate-the-effect-of-exenatide-on-gastric-emptying-in-subjects-with-type-2-diabetes-21653https://curecurrent.com/trials/islet-transplantation-through-an-indwelling-catheter-in-the-umbilical-vein-21654https://curecurrent.com/trials/evaluation-of-the-effect-on-glucose-control-and-safety-of-ac2993-in-patients-with-type-2-diabetes-treated-with-metformin-21655https://curecurrent.com/trials/conjunctival-flora-patterns-after-serial-intravitreal-injections-in-diabetic-patients-21656https://curecurrent.com/trials/study-of-the-efficacy-of-pedyphar-ointment-on-the-diabetic-foot-ulcers-21657https://curecurrent.com/trials/the-pk-pd-efficacy-safety-and-tolerability-study-of-shr3824-in-type-2-diabetes-mellitus-patients-21658https://curecurrent.com/trials/dose-range-finding-study-of-mk-0941-in-patients-with-type-2-diabetes-mellitus-on-insulin-mk-0941-007-am3-ext1-am1-termin-21659https://curecurrent.com/trials/postprandial-blood-glucose-control-and-gastric-emptying-in-type-1-diabetes-pathogenetic-factors-and-therapeutic-options-21660https://curecurrent.com/trials/the-pk-pd-efficacy-safety-and-tolerability-study-of-shr3824-in-combination-with-metformin-in-type-2-diabetes-mellitus-pa-21661https://curecurrent.com/trials/a-trial-investigating-the-absolute-bioavailability-of-insulin-degludec-in-healthy-subjects-21662https://curecurrent.com/trials/safety-and-efficacy-of-yh14617-in-diabetes-mellitus-21663https://curecurrent.com/trials/activating-brown-adipose-tissue-through-exercise-21664https://curecurrent.com/trials/effects-of-glucagon-like-peptide-1-glp-1-and-liraglutide-on-brain-satiety-and-reward-circuits-and-feeding-behavior-in-di-21665https://curecurrent.com/trials/life-long-tele-monitoring-of-patients-with-type-2-diabetes-mellitus-in-central-greece-21666https://curecurrent.com/trials/morphological-and-functional-retinal-changes-following-retinal-photocoagulation-21667https://curecurrent.com/trials/an-investigational-drug-study-to-assess-weight-loss-in-patients-with-type-2-diabetes-mellitus-0364-011-terminated-21668https://curecurrent.com/trials/does-the-natural-medicinal-plant-st-john-s-wort-affect-the-glucose-tolerance-in-healthy-individuals-21669https://curecurrent.com/trials/an-internet-cognitive-behavioral-intervention-for-youth-with-type-1-diabetes-participation-and-efficacy-21670https://curecurrent.com/trials/identifying-progression-of-retinal-disease-in-eyes-with-npdr-in-diabetes-type-2-using-non-invasive-procedures-21671https://curecurrent.com/trials/the-pk-pd-study-of-multiple-dose-of-shr3824-in-healthy-volunteers-21672https://curecurrent.com/trials/role-of-sleep-apnea-and-sympathetic-activity-in-resistant-hypertensive-patients-21673https://curecurrent.com/trials/study-a-mk0767-monotherapy-study-21674https://curecurrent.com/trials/renal-insufficiency-and-cardiovascular-events-21675https://curecurrent.com/trials/a-study-to-evaluate-pharmacodynamics-safety-tolerability-and-pharmacokinetics-of-mt-3995-in-type-ii-diabetic-nephropathy-21676https://curecurrent.com/trials/a-study-to-evaluate-pharmacodynamics-safety-tolerability-and-pharmacokinetics-of-mt-3995-in-type-ii-diabetic-nephropathy-21677https://curecurrent.com/trials/optifit-optimal-fiber-trial-for-diabetes-prevention-21678https://curecurrent.com/trials/the-pk-pd-study-of-single-dose-of-shr3824-in-healthy-volunteers-21679https://curecurrent.com/trials/mulberry-leaf-extract-and-blood-glucose-control-in-diabetics-21680https://curecurrent.com/trials/an-intervention-for-elderly-in-emergency-services-21681https://curecurrent.com/trials/function-and-structure-imaging-in-different-retinal-diseases-retinal-leakage-analyzer-versus-optical-coherence-tomograph-21682https://curecurrent.com/trials/addition-of-liraglutide-to-patients-with-type-2-diabetes-treated-with-multiple-daily-insulin-injections-21683https://curecurrent.com/trials/telecoaching-of-people-with-type-2-diabetes-in-primary-care-21684https://curecurrent.com/trials/pharmacodynamics-pharmacokinetics-safety-and-tolerability-of-shr3824-in-type-2-diabetes-mellitus-patients-21685https://curecurrent.com/trials/investigation-of-the-effect-of-8-week-controlled-high-intense-interval-training-in-type-2-diabetic-patients-21686https://curecurrent.com/trials/vldl-and-ldl-particle-types-as-coronary-heart-disease-risk-factors-21687https://curecurrent.com/trials/effect-of-a-high-fat-meal-on-the-pharmacokinetics-of-shr3824-and-mass-balance-study-in-healthy-subjects-21688https://curecurrent.com/trials/retinal-thickness-analysis-using-optical-coherence-tomography-21689https://curecurrent.com/trials/an-open-label-single-multiple-dose-study-to-investigate-the-pharmacokinetics-of-sitagliptin-100-mg-in-healthy-chinese-ad-21690https://curecurrent.com/trials/hiie-and-abdominal-fat-mass-in-dt2-postmenopausal-women-21691https://curecurrent.com/trials/effect-of-low-glycemic-index-mediterranean-diet-on-ages-21692https://curecurrent.com/trials/time-course-of-the-blood-pressure-lowering-effect-of-liraglutide-therapy-in-type-2-diabetes-21693https://curecurrent.com/trials/peripheral-nerve-stimulation-in-diabetic-patients-21694https://curecurrent.com/trials/discontinuation-order-of-vasopressors-in-septic-shock-21695https://curecurrent.com/trials/comparison-of-two-liraglutide-formulations-in-healthy-subjects-21696https://curecurrent.com/trials/a-sardine-diet-intervention-study-to-assess-benefits-to-the-metabolic-profile-in-type-2-diabetes-mellitus-patients-21697https://curecurrent.com/trials/evaluation-of-optimal-dosing-conditions-for-glp-1-analogue-nnc0113-0987-when-administered-orally-in-healthy-male-subject-21698https://curecurrent.com/trials/a-study-of-ly2189265-in-japanese-participants-with-type-2-diabetes-mellitus-21699https://curecurrent.com/trials/a-telematic-program-for-optimization-of-metabolic-control-in-diabetes-mellitus-type-1-dm1-patients-21700https://curecurrent.com/trials/the-effect-of-shear-force-at-the-skin-in-patients-with-diabetes-mellitus-21701https://curecurrent.com/trials/effect-of-laparoscopic-roux-en-y-gastric-bypass-surgery-on-non-severe-obesity-with-type-2-diabetes-mellitus-21702https://curecurrent.com/trials/efficacy-and-mechanism-of-exenatide-on-improving-heart-function-in-type-2-diabetes-with-heart-failure-patients-21703https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-study-of-mt-3995-in-subjects-with-diabetic-nephropathy-21704https://curecurrent.com/trials/impact-of-pantoprazole-on-24-h-glycemic-control-and-on-post-prandial-glucose-excursion-in-patients-with-type-2-diabetes-21705https://curecurrent.com/trials/effect-of-systemic-oxygen-on-corneal-epithelial-wound-healing-in-diabetic-patients-undergoing-pars-plana-vitrectomy-21706https://curecurrent.com/trials/outpatient-nurse-managed-counseling-program-for-patients-with-diabetic-foot-ulceration-21707https://curecurrent.com/trials/investigating-the-pharmacokinetics-of-subcutaneous-injections-with-1-mg-ml-3-mg-ml-and-10-mg-ml-semaglutide-strengths-an-21708https://curecurrent.com/trials/impact-of-combined-of-lantus-insulin-glargine-and-lyxumia-lixisenatide-on-insulin-secretion-and-gastric-emptying-21709https://curecurrent.com/trials/health2010-14-monitoring-biomarkers-of-chronic-diseases-in-the-general-population-21710https://curecurrent.com/trials/efficacy-study-of-nicorandil-on-neointima-21711https://curecurrent.com/trials/a-cross-sectional-survey-to-evaluate-diabetes-management-control-complications-psychosocial-aspects-of-patients-with-typ-21712https://curecurrent.com/trials/efficacy-and-safety-comparison-of-metformin-glimepiride-combination-versus-each-compound-alone-in-new-diagnosed-type-2-d-21713https://curecurrent.com/trials/trial-to-assess-the-influence-of-4-weeks-treatment-with-linagliptin-as-compared-to-glimepiride-and-placebo-on-endothelia-21714https://curecurrent.com/trials/a-study-in-participants-with-type-2-diabetes-mellitus-award-2-21715https://curecurrent.com/trials/combined-basal-bolus-insulin-and-post-exercise-carbohydrate-feeding-strategy-in-t1dm-21716https://curecurrent.com/trials/evaluating-system-accuracy-of-blood-glucose-monitoring-systems-for-self-testing-in-managing-diabetes-mellitus-21717https://curecurrent.com/trials/comparison-of-two-insulin-detemir-formulations-in-healthy-volunteers-21718https://curecurrent.com/trials/assessment-of-blood-glucose-monitoring-systems-evaluation-of-oxygen-dependency-21719https://curecurrent.com/trials/effect-of-csii-and-cgm-on-progression-of-late-diabetic-complications-21720https://curecurrent.com/trials/bioequivalence-of-two-liraglutide-formulations-in-healthy-volunteers-21721https://curecurrent.com/trials/to-evaluate-clinical-outcome-and-injection-compliance-of-scilin-21722https://curecurrent.com/trials/1-deamino-8-d-arginine-vasopressin-ddavp-in-percutaneous-ultrasound-guided-renal-biopsy-21723https://curecurrent.com/trials/nutrition-education-intervention-in-adults-with-type-2-diabetes-mellitus-in-a-resource-poor-setting-21724https://curecurrent.com/trials/randomized-study-of-yohimbine-treatment-for-type-2-diabetes-patients-carrying-a-specific-genetic-risk-variant-21725https://curecurrent.com/trials/comparison-of-cilotax-stent-and-everolimus-eluting-stent-with-diabetes-mellitus-essence-dm-iii-21726https://curecurrent.com/trials/basal-bolus-and-premixed-insulin-regimens-in-hospitalized-patients-with-type-2-diabetes-pinin-study-21727https://curecurrent.com/trials/evolution-with-cpap-treatment-of-a-cohort-of-type-2-diabetic-patients-with-apnea-hypopnea-syndrome-21728https://curecurrent.com/trials/effect-of-bariatric-surgery-versus-optimal-medical-therapy-on-cardiovascular-health-and-atherosclerosis-in-obese-type-ii-21729https://curecurrent.com/trials/affect-of-incentive-strategy-on-the-adherence-to-medication-among-patients-with-type-2-diabetes-21730https://curecurrent.com/trials/the-effect-of-guided-imagery-in-children-with-type-1-diabetes-mellitus-on-glucose-levels-and-on-glycemic-control-21731https://curecurrent.com/trials/fats-and-carbohydrates-quality-on-postprandial-glycemic-response-in-type-1-diabetes-21732https://curecurrent.com/trials/hyperbaric-oxygen-therapy-in-diabetics-with-chronic-foot-ulcers-and-improvement-of-quality-of-life-21733https://curecurrent.com/trials/a-trial-investigating-the-influence-of-injection-speed-and-volume-on-the-perception-of-subcutaneous-injection-pain-21734https://curecurrent.com/trials/a-trial-to-compare-the-pk-and-pd-of-insulin-lispro-administered-into-different-tissues-in-subjects-with-diabetes-mellitu-21735https://curecurrent.com/trials/relationships-between-mean-plasma-glucose-and-hba1c-in-cirrhotic-patients-with-hepatogenous-diabetes-21736https://curecurrent.com/trials/single-dose-clamp-study-to-compare-concentration-time-profile-and-metabolic-activity-profile-of-2-new-formulations-of-in-21737https://curecurrent.com/trials/post-prandial-glucose-ppg-study-of-empagliflozin-in-japanese-patients-with-type-2-diabetes-mellitus-21738https://curecurrent.com/trials/assessment-of-efficacy-of-vardenafil-in-subjects-with-erectile-dysfunction-and-diabetes-hypertension-or-hyperlipidemia-21739https://curecurrent.com/trials/system-accuracy-and-user-performance-of-blood-glucose-monitoring-systems-for-self-testing-in-managing-diabetes-mellitus-21740https://curecurrent.com/trials/rapid-effects-linagliptin-on-monocyte-polarization-and-endothelial-progenitor-cells-in-type-2-diabetes-21741https://curecurrent.com/trials/evaluation-of-video-on-demand-programming-to-prevent-type-2-diabetes-in-adults-21742https://curecurrent.com/trials/bay38-9456-pivotal-trial-for-diabetes-patient-21743https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-effectiveness-of-dm199-in-healthy-subjects-and-type-2-diabetes-patients-21744https://curecurrent.com/trials/correlation-of-irisin-and-adipokine-levels-with-body-mass-index-and-risk-factors-for-metabolic-syndrome-in-hispanic-chil-21745https://curecurrent.com/trials/microclinic-social-induction-pilot-intervention-for-diabetes-and-obesity-management-in-qatar-21746https://curecurrent.com/trials/estudo-longitudinal-de-sa-de-do-adulto-brazilian-longitudinal-study-of-adult-health-21747https://curecurrent.com/trials/topical-application-of-latanoprost-in-diabetic-retinopathy-21748https://curecurrent.com/trials/a-multicenter-study-to-compare-multiple-doses-of-intravitreal-microplasmin-versus-sham-injection-for-treatment-of-patien-21749https://curecurrent.com/trials/copeptin-in-the-diagnosis-and-differential-diagnosis-of-diabetes-insipidus-the-cosip-study-21750https://curecurrent.com/trials/efficacy-of-novel-edible-gel-based-artificial-saliva-in-thai-geriatric-populations-with-systemic-diseases-21751https://curecurrent.com/trials/long-term-study-of-kad-1229-in-type-2-diabetes-patients-21752https://curecurrent.com/trials/comparative-study-of-3-dose-regimens-of-biochaperone-to-becaplermin-gel-for-the-treatment-of-diabetic-foot-ulcer-21753https://curecurrent.com/trials/self-management-in-type-2-diabetes-patients-using-the-few-touch-application-21754https://curecurrent.com/trials/evaluation-of-efficacy-and-safety-of-vardenafil-in-patients-with-erectile-dysfunction-and-type-1-diabetes-21755https://curecurrent.com/trials/hypoglycemia-associated-autonomic-failure-in-type-1-diabetes-mellitus-21756https://curecurrent.com/trials/hypoglycemia-associated-autonomic-failure-in-type-1-dm-q4-21757https://curecurrent.com/trials/evaluate-the-efficacy-of-fenofibrate-on-microalbuminuria-21758https://curecurrent.com/trials/glimepiride-induced-insulin-secretion-will-be-inhibited-by-hypoglycemia-21759https://curecurrent.com/trials/exploratory-csii-trial-on-erectile-dysfunction-in-t2dm-patients-21760https://curecurrent.com/trials/hypoglycemia-associated-autonomic-failure-in-type-1-dm-q5-21761https://curecurrent.com/trials/metabolic-adaptation-to-diabetes-21762https://curecurrent.com/trials/metabolic-adaptations-to-diabetes-in-african-americans-21763https://curecurrent.com/trials/insulin-exposure-and-glucose-response-to-meals-in-type-1-diabetic-subjects-administered-two-different-insulin-regimens-c-21764https://curecurrent.com/trials/patient-centered-smartphone-based-diabetes-care-21765https://curecurrent.com/trials/early-detection-of-cognitive-dysfunction-in-diabetes-21766https://curecurrent.com/trials/the-effect-of-a-checklist-on-the-quality-of-education-during-insulin-initiation-by-trained-medical-students-21767https://curecurrent.com/trials/islet-function-and-clinical-analyses-of-transplant-recipients-21768https://curecurrent.com/trials/a-double-blinded-randomised-four-period-crossover-euglycemic-clamp-trial-investigating-the-dose-response-and-dose-exposu-21769https://curecurrent.com/trials/study-of-welltang-a-cell-phone-based-diabetes-management-application-s-effect-on-blood-glucose-control-21770https://curecurrent.com/trials/safety-of-liraglutide-in-subjects-with-liver-impairment-and-in-subjects-with-normal-liver-function-21771https://curecurrent.com/trials/the-effect-of-type-2-diabetes-and-dietary-regulation-on-vldl1-and-vldl2-triglyceride-metabolism-21772https://curecurrent.com/trials/prospective-assessment-of-meos-telemedicine-e-portal-on-ambulatory-care-of-type-1-diabetic-patients-21773https://curecurrent.com/trials/prospective-randomized-clinical-trial-comparing-macular-photocoagulation-with-or-without-intravitreal-bevacizumab-or-tri-21774https://curecurrent.com/trials/efficacy-and-safety-of-biphasic-insulin-aspart-30-in-type-2-diabetes-mellitus-when-failing-on-oads-21775https://curecurrent.com/trials/surgical-techniques-in-diabetes-mellitus-ii-and-obesity-metabolic-surgery-study-mss-21776https://curecurrent.com/trials/evaluation-of-iphone-technology-in-diabetes-treatment-21777https://curecurrent.com/trials/the-effect-of-vinegar-on-glucose-and-lipid-metabolism-in-subjects-with-impaired-glucose-tolerance-or-type-2-diabetes-21778https://curecurrent.com/trials/health-care-for-type-1-diabetes-in-developing-world-21779https://curecurrent.com/trials/trial-of-a-new-formulation-of-krx-0502-ferric-citrate-in-patients-with-end-stage-renal-disease-21780https://curecurrent.com/trials/bio-connekt-wound-dressing-for-treatment-of-chronic-leg-wounds-a-pilot-study-21781https://curecurrent.com/trials/a-diabetes-prevention-study-targeting-high-risk-individuals-with-education-and-ongoing-support-21782https://curecurrent.com/trials/the-impact-of-reformulated-foods-on-cardiovascular-risk-factors-21783https://curecurrent.com/trials/intravitreous-bevacizumab-and-standard-metabolic-control-for-diabetic-macular-edema-a-contrast-sensitivity-study-21784https://curecurrent.com/trials/effects-of-moringa-oleifera-on-hscrp-and-hgba1c-level-of-patients-in-ospital-ng-maynila-medical-center-diabetic-clinic-21785https://curecurrent.com/trials/effects-of-education-program-for-lebanese-diabetic-t2-in-their-behavior-of-auto-managing-of-self-efficacy-and-adhesion-21786https://curecurrent.com/trials/interaction-between-st-john-s-wort-and-metformin-21787https://curecurrent.com/trials/evaluation-of-the-effects-of-heating-the-vicinity-of-the-insulin-delivery-site-by-the-experimental-device-21788https://curecurrent.com/trials/incretins-and-metabolism-21789https://curecurrent.com/trials/a-trial-to-assess-the-pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-oral-semaglutide-in-healthy-male-japa-21790https://curecurrent.com/trials/study-of-metformin-pharmacogenetics-in-twins-21791https://curecurrent.com/trials/diabetes-incentive-performance-study-dips-at-shanghai-jiading-district-21792https://curecurrent.com/trials/exercise-training-and-type-2-diabetes-21793https://curecurrent.com/trials/glucolipotoxicity-and-type-2-diabetes-21794https://curecurrent.com/trials/insulin-secretion-and-advagraf-21795https://curecurrent.com/trials/ease-of-use-and-safety-of-the-new-u300-pen-injector-in-insulin-na-ve-patients-with-t2dm-21796https://curecurrent.com/trials/sleevediab-to-explore-the-early-and-late-metabolic-effects-of-sleeve-gastrectomy-in-obese-patients-21797https://curecurrent.com/trials/effects-of-peer-support-and-yoga-music-on-t2dm-with-depression-and-sleep-disorders-21798https://curecurrent.com/trials/a-clinical-trial-to-investigate-safety-tolerability-and-pharmacokinetics-of-da-1229-01-compared-to-co-administration-of-21799https://curecurrent.com/trials/diet-oil-induced-stimulation-of-glp-1-21800https://curecurrent.com/trials/islet-of-langerhans-graft-monitoring-by-magnetic-resonance-imaging-21801https://curecurrent.com/trials/efficacy-and-safety-of-prescription-omega-3-fatty-acid-added-to-stable-statin-therapy-in-patients-with-type-2-diabetes-a-21802https://curecurrent.com/trials/glp-1-receptor-targeting-in-diabetic-and-healthy-individuals-21803https://curecurrent.com/trials/the-role-of-fto-gene-polymorphism-and-insulin-preparation-in-obesity-in-children-with-type-1-diabetes-mellitus-21804https://curecurrent.com/trials/short-term-closed-loop-glucose-control-in-adults-with-type-1-diabetes-21805https://curecurrent.com/trials/baseline-physiology-studies-in-carriers-of-gene-variant-x-conferring-major-risk-of-cvd-prone-metabolic-disorders-21806https://curecurrent.com/trials/a-cross-sectional-survey-to-evaluate-diabetes-management-control-complications-psychosocial-aspects-of-patients-with-typ-21807https://curecurrent.com/trials/prf-growth-factors-levels-in-diabetic-patients-with-chronic-periodontitis-21808https://curecurrent.com/trials/stem-cell-therapy-for-patients-with-vascular-occlusive-diseases-such-as-diabetic-foot-21809https://curecurrent.com/trials/study-to-compare-2-doses-of-polycap-versus-single-dose-of-polycap-with-or-without-pottasium-21810https://curecurrent.com/trials/exogenous-glucose-oxidation-breath-test-21811https://curecurrent.com/trials/insulin-by-jet-injection-for-hyperglycemia-in-diabetes-21812https://curecurrent.com/trials/study-design-of-influence-of-sarpogrelate-in-patients-with-renal-impairment-or-diabetes-mellitus-study-21813https://curecurrent.com/trials/4-weeks-treatment-with-empagliflozin-bi-10773-in-japanese-type-2-diabetic-patients-t2dm-21814https://curecurrent.com/trials/choroidal-blood-flow-changes-during-dark-light-transitions-in-patients-with-insulin-dependent-diabetes-mellitus-iddm-21815https://curecurrent.com/trials/effect-of-local-application-of-boron-on-diabetic-foot-ulcers-21816https://curecurrent.com/trials/linagliptin-in-combination-with-metformin-in-treatment-naive-patients-with-type-2-diabetes-mellitus-and-insufficient-gly-21817https://curecurrent.com/trials/metformin-versus-insulin-in-gestational-diabetes-21818https://curecurrent.com/trials/audit-and-feedback-for-primary-care-a-cluster-randomized-trial-21819https://curecurrent.com/trials/fecal-microbiota-transplantation-on-type-2-diabetes-mellitus-21820https://curecurrent.com/trials/evaluation-of-a-toolkit-to-improve-cardiovascular-disease-screening-and-treatment-for-people-with-diabetes-21821https://curecurrent.com/trials/advanced-carbohydrate-counting-and-automated-bolus-calculation-21822https://curecurrent.com/trials/evaluation-of-a-toolkit-to-improve-cardiovascular-disease-screening-and-treatment-for-people-with-type-2-diabetes-21823https://curecurrent.com/trials/emma-empowerment-motivation-and-medical-adherence-21824https://curecurrent.com/trials/effect-of-rosuvastatin-on-endothelial-function-in-patients-with-diabetes-and-glaucoma-21825https://curecurrent.com/trials/efficacy-and-safety-of-a-fixed-or-a-flexible-supplementary-insulin-therapy-in-type-2-diabetes-21826https://curecurrent.com/trials/web-based-insulin-titration-an-efficacy-study-21827https://curecurrent.com/trials/effect-of-paired-testing-to-poorly-controlled-chinese-diabetes-on-glycemic-control-and-self-care-21828https://curecurrent.com/trials/registry-of-first-line-treatments-in-patients-with-critical-limb-ischemia-21829https://curecurrent.com/trials/community-approach-to-reduce-the-risks-of-diabetes-after-gestational-diabetes-mellitus-21830https://curecurrent.com/trials/alternative-delivery-of-dose-adjustment-for-normal-eating-dafne-trial-in-patients-with-type-1-diabetes-21831https://curecurrent.com/trials/diabetes-in-neuropsychiatric-disorders-21832https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-multiple-rising-oral-doses-of-bi-135585-xx-in-patients-with-21833https://curecurrent.com/trials/dare-diabetes-in-cardiac-rehabilitation-21834https://curecurrent.com/trials/vitamin-d-supplementation-in-patients-with-diabetes-mellitus-type-2-21835https://curecurrent.com/trials/acute-effects-of-inspiratory-muscle-exercise-on-glucose-level-and-glucose-variability-in-patients-with-type-2-diabetes-21836https://curecurrent.com/trials/evaluation-of-topical-citrullus-colocynthis-fruit-oil-efficacy-in-treatment-of-painful-peripheral-diabetic-neuropathy-21837https://curecurrent.com/trials/autologous-bone-marrow-derived-mononuclear-cells-in-treating-diabetic-patients-with-critical-limb-ischemia-21838https://curecurrent.com/trials/roux-en-y-gastric-bypass-rygb-versus-omega-loop-gastric-bypass-olgb-safety-and-efficacy-short-term-study-21839https://curecurrent.com/trials/study-investigating-the-levels-and-effects-of-low-grade-inflammation-in-diabetic-retinopathy-of-type-1-diabetes-21840https://curecurrent.com/trials/comparing-laboratory-blood-glucose-results-with-hemocue-glucose-201-rt-21841https://curecurrent.com/trials/comparison-of-sequential-iv-po-moxifloxacin-with-iv-piperacillin-tazobactam-followed-by-po-amoxicillin-clavulanic-acid-i-21842https://curecurrent.com/trials/outcome-of-second-generation-drug-eluting-stents-in-patients-with-diabetes-mellitus-21843https://curecurrent.com/trials/can-gluten-free-diet-prevent-the-destruction-of-beta-cells-during-remission-21844https://curecurrent.com/trials/anti-hyperglycemic-effect-of-short-term-arginyl-fructose-supplementation-in-subjects-with-pre-diabetes-and-newly-diagnos-21845https://curecurrent.com/trials/vasopressin-in-traumatic-hemorrhagic-shock-study-21846https://curecurrent.com/trials/chronic-effects-of-two-aerobic-training-models-performed-in-water-and-on-dry-land-in-patients-with-type-2-diabetes-melli-21847https://curecurrent.com/trials/effect-of-linagliptin-on-trl-metabolism-21848https://curecurrent.com/trials/effect-of-a-treatment-of-lifestyle-changes-on-the-prevalence-of-metabolic-syndrome-and-body-weight-in-mexican-women-21849https://curecurrent.com/trials/comparison-of-insulin-detemir-and-insulin-aspart-in-2-separate-injections-twice-daily-to-extemporaneous-mixing-injection-21850https://curecurrent.com/trials/efficacy-and-tolerability-of-novel-a2a-agonist-in-treatment-of-diabetic-neuropathic-pain-21851https://curecurrent.com/trials/lypo-hypertrofia-characterization-in-diabetes-21852https://curecurrent.com/trials/comparison-of-two-biphasic-insulin-aspart-30-treatment-regimens-in-subjects-with-type-2-diabetes-not-achieving-hba1c-tre-21853https://curecurrent.com/trials/basal-bolus-versus-human-insulin-in-hospitalized-patients-with-diabetes-in-paraguay-21854https://curecurrent.com/trials/percentage-of-secondary-prevention-patients-treated-to-their-ldl-c-targets-21855https://curecurrent.com/trials/percentage-of-secondary-prevention-patients-treated-to-their-ldl-c-targets-21856https://curecurrent.com/trials/diabetic-under-70-diabetics-below-70-21857https://curecurrent.com/trials/observational-study-to-observe-the-safety-of-levemir-treatment-in-patients-with-type-2-diabetes-21858https://curecurrent.com/trials/e-health-care-process-support-for-diabetes-type-ii-patients-21859https://curecurrent.com/trials/effects-of-pinitol-on-hidrocarbonated-metabolism-parameters-in-diabetic-impaired-and-normal-fasting-glucose-subjects-21860https://curecurrent.com/trials/feasibility-study-of-the-jewelpump-version-3-21861https://curecurrent.com/trials/creation-of-a-patient-database-for-silicon-patient-simulation-glucose-sensor-variability-and-pharmacokinetic-study-of-de-21862https://curecurrent.com/trials/pioglitazone-and-losartan-provides-additional-renoprotection-21863https://curecurrent.com/trials/efficacy-and-safety-of-empagliflozin-versus-sitagliptin-in-patients-with-type-2-diabetes-21864https://curecurrent.com/trials/comparison-of-biphasic-insulin-aspart-30-twice-daily-with-two-different-initial-dosage-split-regimens-in-subjects-with-t-21865https://curecurrent.com/trials/initial-testing-of-the-diabeloop-algorithm-in-t1d-patients-on-pump-therapy-over-the-prandial-period-and-physical-activit-21866https://curecurrent.com/trials/evaluation-of-dapagliflozin-taken-twice-daily-21867https://curecurrent.com/trials/stem-cell-mobilization-with-plerixafor-in-diabetic-vs-control-subjects-21868https://curecurrent.com/trials/skype-for-youth-with-poorly-controlled-diabetes-21869https://curecurrent.com/trials/a-study-to-compare-pharmacokinetics-and-pharmacodynamics-of-sar342434-to-insulin-lispro-in-subjects-with-type-1-diabetes-21870https://curecurrent.com/trials/safety-efficacy-and-cost-efficacy-of-ranibizumab-monotherapy-or-combination-with-laser-in-the-treatment-of-diabetic-macu-21871https://curecurrent.com/trials/relationship-between-hba1c-fasting-plasma-glucose-post-prandial-glucose-and-other-measures-of-glycemic-control-21872https://curecurrent.com/trials/effect-of-biphasic-insulin-aspart-50-on-blood-glucose-control-in-subjects-with-type-2-diabetes-21873https://curecurrent.com/trials/effect-of-food-on-the-pharmacokinetics-of-oral-semaglutide-in-healthy-subjects-21874https://curecurrent.com/trials/closed-loop-control-of-overnight-glucose-levels-in-adults-and-adolescents-with-type-1-diabetes-21875https://curecurrent.com/trials/rectal-short-chain-fatty-acids-combinations-and-substrate-and-energy-metabolism-21876https://curecurrent.com/trials/special-drug-use-investigation-of-glucobay-od-21877https://curecurrent.com/trials/a-study-of-dulaglutide-in-japanese-participants-with-type-2-diabetes-mellitus-21878https://curecurrent.com/trials/a-trial-to-investigate-safety-and-efficacy-of-spm927-in-painful-diabetic-neuropathy-21879https://curecurrent.com/trials/home-bicycle-exercise-and-aerobic-capacity-21880https://curecurrent.com/trials/recurrent-hypoglycaemia-in-type-1-diabetes-21881https://curecurrent.com/trials/a-study-comparing-subcutaneous-rapid-acting-insulin-and-one-formulation-of-inhaled-insulin-in-subjects-with-type-2-diabe-21882https://curecurrent.com/trials/a-prospective-randomized-trial-to-compare-saroglitazar-with-pioglitazone-in-nonalcoholic-fatty-liver-disease-21883https://curecurrent.com/trials/exercise-as-a-tool-for-studying-the-mechanisms-and-applicability-of-glycemic-variability-21884https://curecurrent.com/trials/fat-induced-release-of-glp-1-in-humans-21885https://curecurrent.com/trials/ubiquitous-healthcare-service-with-multifactorial-intervention-in-diabetes-care-21886https://curecurrent.com/trials/a-study-in-participants-with-diabetic-peripheral-neuropathic-pain-in-china-21887https://curecurrent.com/trials/a-clinical-trial-to-study-the-effect-of-lycopene-in-patients-with-gum-disease-and-type2-diabetes-mellitus-21888https://curecurrent.com/trials/post-marketing-surveillance-study-in-rehabilitation-clinics-cardio-nephro-diabetes-pulmo-21889https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-advagraf-vs-prograf-in-kidney-transplantation-patients-1-month-after-the-tr-21890https://curecurrent.com/trials/oleoyl-glycerol-is-a-gpr119-agonist-and-signals-glp-1-release-in-humans-21891https://curecurrent.com/trials/efficacy-and-safety-of-dlbs3233-in-subjects-with-new-onset-of-type-2-diabetes-mellitus-21892https://curecurrent.com/trials/effect-of-ly2189265-on-insulin-secretion-in-response-to-intravenous-glucose-21893https://curecurrent.com/trials/insulin-glulisine-and-aspart-in-postprandial-glycemic-control-after-high-gi-meal-in-children-with-type-1-diabetes-mellit-21894https://curecurrent.com/trials/the-role-of-metformin-and-colesevelam-in-human-glp-1-secretion-21895https://curecurrent.com/trials/a-study-to-compare-the-pharmacokinetics-and-pharmacodynamics-of-ly2963016-to-lantus-in-healthy-participants-21896https://curecurrent.com/trials/salusin-alpha-a-new-factor-in-the-pathogenesis-of-lipid-abnormalities-in-hemodialysis-patients-21897https://curecurrent.com/trials/a-comparison-of-ly2963016-to-a-basal-insulin-after-a-single-dose-in-healthy-subjects-21898https://curecurrent.com/trials/a-study-to-compare-ly2963016-to-lantus-after-a-single-dose-to-participants-with-type-1-diabetes-mellitus-21899https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-ly2189265-on-the-speed-at-which-food-and-drink-leaves-the-stomach-in-patients-with-typ-21900https://curecurrent.com/trials/a-single-dose-study-of-ly2189265-in-subjects-with-varying-degrees-of-hepatic-liver-impairment-21901https://curecurrent.com/trials/a-first-in-human-study-of-ly3009385-in-healthy-participants-21902https://curecurrent.com/trials/improved-delivery-of-cardiovascular-care-through-outreach-facilitation-21903https://curecurrent.com/trials/observatory-on-elderly-patients-les-s-ages-21904https://curecurrent.com/trials/a-clinical-trial-to-study-the-effects-grc-17536-in-patients-with-painful-diabetic-peripheral-neuropathy-painful-extremit-21905https://curecurrent.com/trials/effects-of-different-surgical-methods-to-treat-obesity-21906https://curecurrent.com/trials/a-cross-sectional-survey-to-evaluate-diabetes-management-control-complications-psychosocial-aspects-of-patients-with-typ-21907https://curecurrent.com/trials/rct-examining-effects-of-probiotics-in-t2dm-individuals-21908https://curecurrent.com/trials/early-feasibility-study-2-of-outpatient-control-to-range-testing-system-efficacy-italy-21909https://curecurrent.com/trials/ranibizumab-treatment-of-diabetic-macular-oedema-with-bimonthly-monitoring-after-a-phase-of-initial-treatment-21910https://curecurrent.com/trials/vildagliptin-and-the-glucagon-response-to-hypoglycemia-in-insulin-treated-patients-with-type-2-diabetes-21911https://curecurrent.com/trials/assessment-of-beta-cell-mass-by-pet-scans-with-11c-dihydrotetrabenazine-dtbz-in-longstanding-type-1-diabetes-21912https://curecurrent.com/trials/effect-of-saxagliptin-on-pre-diabetes-mellitus-and-obesity-21913https://curecurrent.com/trials/effects-of-high-dose-resveratrol-in-non-diabetic-obese-males-21914https://curecurrent.com/trials/evaluate-efficacy-study-of-combination-therapy-of-everolimus-and-low-dose-tacrolimus-in-renal-allograft-recipients-21915https://curecurrent.com/trials/safety-study-of-maraviroc-s-effect-on-human-osteoclasts-21916https://curecurrent.com/trials/influence-of-diabetes-on-tramadol-pharmacokinetics-21917https://curecurrent.com/trials/a-trial-to-assess-the-efficacy-and-safety-of-spm-927-lacosamide-in-subjects-with-painful-distal-diabetic-neuropathy-21918https://curecurrent.com/trials/verifynow-in-diabetes-non-responsiveness-a-study-on-switching-from-clopidogrel-to-prasugrel-21919https://curecurrent.com/trials/bed-rest-alternate-daily-fasting-and-incretin-effect-21920https://curecurrent.com/trials/prevention-of-secondary-foot-ulcers-in-patients-with-diabetes-using-systematic-measuring-of-skin-temperature-21921https://curecurrent.com/trials/empowering-primary-care-providers-and-patients-to-improve-chronic-disease-outcomes-the-empower-participatory-action-rese-21922https://curecurrent.com/trials/correlation-between-vitamin-d-levels-to-adamts13-vwf-and-micro-rna-expression-in-diabetic-hemodialysis-patients-21923https://curecurrent.com/trials/linagliptin-among-filipino-patients-with-type-2-diabetes-mellitus-21924https://curecurrent.com/trials/effects-of-different-types-of-anesthesia-on-stress-response-in-laparoscopic-gastric-bypass-for-type-2-diabetes-mellitus-21925https://curecurrent.com/trials/study-safety-and-efficacy-of-bone-marrow-derived-autologous-cells-for-the-treatment-of-diabetes-mellitus-21926https://curecurrent.com/trials/study-to-evaluate-the-effect-of-micardis-micardisplus-on-metabolic-parameters-in-patients-with-essential-hypertension-an-21927https://curecurrent.com/trials/diabetes-mellitus-at-the-university-medical-center-of-mannheim-21928https://curecurrent.com/trials/predictive-value-of-contrast-volume-to-creatinine-clearance-ratio-21929https://curecurrent.com/trials/glucose-tolerance-in-acromegaly-the-influence-of-gh-excess-on-glucose-metabolism-and-insulin-resistance-21930https://curecurrent.com/trials/safety-and-efficacy-of-overnight-closed-loop-in-children-with-type-1diabetes-mellitus-in-luxembourg-21931https://curecurrent.com/trials/efficacy-and-safety-of-ranibizumab-in-two-treat-and-extend-treatment-algorithms-versus-ranibizumab-as-needed-in-patients-21932https://curecurrent.com/trials/application-and-effectiveness-analysis-of-internet-based-diabetes-prevention-program-21933https://curecurrent.com/trials/liraglutide-and-beta-cell-repair-libra-study-21934https://curecurrent.com/trials/clinical-trials-for-the-optimal-dosage-of-tang-ning-tongluo-capsule-21935https://curecurrent.com/trials/comparing-internet-blood-glucose-monitoring-system-and-continuous-glucose-monitoring-system-21936https://curecurrent.com/trials/blood-monitoring-and-data-acquisition-and-utilization-in-patients-with-type-2-diabetes-treated-with-insulin-21937https://curecurrent.com/trials/enhancement-of-brown-adipose-tissue-function-via-chronic-pharmacological-treatment-21938https://curecurrent.com/trials/motivational-support-and-meal-preparation-training-to-reduce-vascular-risk-after-gestational-diabetes-21939https://curecurrent.com/trials/effects-of-vitamin-d-on-beta-cell-function-and-insulin-sensitivity-in-pre-diabetes-and-diabetes-mellitus-type-2-21940https://curecurrent.com/trials/insulinotropic-effect-of-glp-1-and-gip-after-dexamethasone-21941https://curecurrent.com/trials/copeptin-during-a-standardized-psychological-stress-test-21942https://curecurrent.com/trials/a-study-to-determine-acute-after-first-dose-and-chronic-after-28-days-effects-of-empagliflozin-bi-10773-on-pre-and-postp-21943https://curecurrent.com/trials/dietary-polyphenols-and-lipid-oxidation-21944https://curecurrent.com/trials/safety-pharmacokinetics-and-pharmacodynamics-study-of-single-dose-of-cnto-3649-in-healthy-adult-men-and-multiple-doses-o-21945https://curecurrent.com/trials/a-non-interventional-study-to-evaluate-diabetes-related-quality-of-life-frequency-and-impact-of-hypoglycemia-in-t2dm-21946https://curecurrent.com/trials/the-insupad-in-daily-life-study-effect-of-local-heating-on-postprandial-glucose-excursions-using-the-insupad-device-21947https://curecurrent.com/trials/resveratrol-and-type-2-diabetes-21948https://curecurrent.com/trials/chromosomal-damage-in-type-2-diabetes-patients-mikrodiab-21949https://curecurrent.com/trials/comparison-of-a-twice-daily-versus-a-three-times-daily-insulin-regimen-in-children-with-type-1-diabetes-21950https://curecurrent.com/trials/closed-loop-control-of-overnight-glucose-levels-artificial-pancreas-in-children-with-type-1-diabetes-in-a-diabetes-camp-21951https://curecurrent.com/trials/pharmacodynamics-and-pharmacokinetics-of-empagliflozin-and-torasemide-in-patients-with-type-2-diabetes-21952https://curecurrent.com/trials/type-ii-diabetes-influence-on-left-ventricular-remodeling-and-outcomes-in-patients-undergoing-aortic-valve-replacement-s-21953https://curecurrent.com/trials/metagenomics-and-integrative-systems-medicine-of-cardiometabolic-diseases-21954https://curecurrent.com/trials/use-of-a-bearable-continuous-interstitial-glucose-monitoring-device-guardianr-during-teaching-sessions-to-functional-ins-21955https://curecurrent.com/trials/a-single-dose-phase-1-study-of-dbpr108-in-healthy-male-subjects-21956https://curecurrent.com/trials/study-of-liraglutide-versus-insulin-on-liver-fat-fraction-in-patients-with-type-2-diabetes-21957https://curecurrent.com/trials/evaluation-of-a-primary-type-2-diabetes-prevention-programme-21958https://curecurrent.com/trials/duodenal-exclusion-for-the-treatment-of-t2dm-21959https://curecurrent.com/trials/neuroendocrine-brake-for-type-2-diabetes-mellitus-21960https://curecurrent.com/trials/etiologies-of-fever-among-adults-in-dar-es-salaam-21961https://curecurrent.com/trials/a-study-of-the-effects-of-canagliflozin-on-plasma-volume-in-patients-with-type-2-diabetes-mellitus-21962https://curecurrent.com/trials/diagnostic-biomarkers-related-to-periodontal-disease-activity-in-diabetic-21963https://curecurrent.com/trials/diabetes-vardenafil-21964https://curecurrent.com/trials/the-influence-of-partial-remission-phase-of-type-1-diabetes-on-patient-outcome-21965https://curecurrent.com/trials/effect-of-magnesium-supplementation-on-patients-with-diabetic-nephropathy-21966https://curecurrent.com/trials/optimal-type-2-diabetes-management-including-benchmarking-and-standard-treatment-in-ceemea-21967https://curecurrent.com/trials/an-observational-study-on-efficacy-and-safety-in-subjects-using-levemir-for-the-treatment-of-insulin-dependent-type-1-or-21968https://curecurrent.com/trials/observational-study-on-levemir-in-obese-diabetic-patients-21969https://curecurrent.com/trials/contrast-sensitivity-and-diabetic-macular-edema-21970https://curecurrent.com/trials/safety-of-novomix-30-or-levemir-for-treatment-of-type-2-diabetics-in-macedonia-21971https://curecurrent.com/trials/observational-study-to-evaluate-the-safety-and-efficacy-of-levemir-in-type-2-diabetes-21972https://curecurrent.com/trials/observational-study-to-observe-the-efficacy-of-levemir-insulin-detemir-in-patients-with-type-2-diabetes-21973https://curecurrent.com/trials/long-term-effects-of-dpp-iv-inhibitor-treatment-in-patients-with-type-2-diabetes-21974https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-multiple-rising-oral-doses-of-bi-44847-in-female-and-male-p-21975https://curecurrent.com/trials/can-soluble-cd163-discriminate-between-healthy-and-unhealthy-obese-individuals-21976https://curecurrent.com/trials/a-pilot-study-to-examine-the-effects-of-ticagrelor-to-protect-against-type-2-diabetes-induced-vascular-damage-21977https://curecurrent.com/trials/effects-of-blueberry-dry-powder-on-glycemic-status-in-subjects-with-prediabetes-21978https://curecurrent.com/trials/evaluation-of-a-self-management-oriented-diabetes-education-program-for-intensified-insulin-therapy-in-type-2-diabetes-21979https://curecurrent.com/trials/observational-safety-study-of-novonorm-repaglinide-and-insulin-analogue-combination-therapy-in-type-2-diabetes-in-korea-21980https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-multiple-rising-oral-doses-of-bi-14332-cl-as-tablet-in-fema-21981https://curecurrent.com/trials/diabetes-intervention-program-for-adolescents-with-persistent-high-ha1c-21982https://curecurrent.com/trials/4-week-treatment-with-three-oral-doses-of-bi-10773-in-patients-with-type-2-diabetes-21983https://curecurrent.com/trials/safety-and-efficacy-study-of-apic-prp-in-non-healing-diabetic-foot-ulcers-21984https://curecurrent.com/trials/the-trafermin-in-neuropathic-diabetic-foot-ulcer-study-northern-europe-the-trans-north-study-21985https://curecurrent.com/trials/the-trafermin-in-neuropathic-diabetic-foot-ulcer-study-southern-europe-the-trans-south-study-21986https://curecurrent.com/trials/teneligliptin-mp-513-versus-placebo-in-type-2-diabetes-mellitus-21987https://curecurrent.com/trials/egg-protein-hydrolysate-and-vascular-function-21988https://curecurrent.com/trials/post-exercise-insulin-reductions-in-type-1-diabetes-21989https://curecurrent.com/trials/post-exercise-appetite-responses-in-type-1-diabetes-21990https://curecurrent.com/trials/glucagon-like-peptide-glp-utilization-and-safety-21991https://curecurrent.com/trials/efficacy-and-safety-of-rhegf-in-diabetic-foot-ulcer-patients-with-uncontrolled-diabetic-mellitus-21992https://curecurrent.com/trials/the-effects-of-hypoglycaemia-in-people-with-type-2-diabetes-21993https://curecurrent.com/trials/magnetic-resonance-imaging-of-vascular-function-21994https://curecurrent.com/trials/bisoprolol-in-hypertension-effect-on-concomitant-elevated-heart-rate-21995https://curecurrent.com/trials/characterization-of-beta-cell-failure-21996https://curecurrent.com/trials/incidence-of-retinopathy-and-associated-risk-factors-in-children-and-young-adults-with-type-1-diabetes-in-denmark-21997https://curecurrent.com/trials/lifestyle-therapy-for-youth-with-type-2-diabetes-21998https://curecurrent.com/trials/comparison-of-zotarolimus-eluting-stent-vs-sirolimus-eluting-stent-for-diabetic-patients-21999https://curecurrent.com/trials/chung-ju-metabolic-disease-cohort-cmc-study-22000